<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Idiopathic pulmonary fibrosis - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Idiopathic_pulmonary_fibrosis" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cmw.PopUpMediaTransform.styles%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Idiopathic_pulmonary_fibrosis","wgTitle":"Idiopathic pulmonary fibrosis","wgCurRevisionId":650179698,"wgRevisionId":650179698,"wgArticleId":8768565,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Articles with contributors link","Articles with hAudio microformats","Commons category with local link same as on Wikidata","Articles with DMOZ links","Articles that use a Medicine navs subtemplate","Respiratory diseases principally affecting the interstitium","Idiopathic diseases"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Idiopathic_pulmonary_fibrosis","wgRelevantArticleId":8768565,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Ipf_NIH.jpg/92px-Ipf_NIH.jpg","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q2290446"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mw.TMHGalleryHook.js","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Idiopathic_pulmonary_fibrosis skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Idiopathic pulmonary fibrosis</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Idiopathic pulmonary fibrosis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Ipf_NIH.jpg" class="image"><img alt="Ipf NIH.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Ipf_NIH.jpg/230px-Ipf_NIH.jpg" width="230" height="250" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Ipf_NIH.jpg/345px-Ipf_NIH.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Ipf_NIH.jpg/460px-Ipf_NIH.jpg 2x" data-file-width="475" data-file-height="516" /></a>
<div><b>Figure A</b> shows the location of the lungs and airways in the body. The inset image shows a detailed view of the lung's airways and air sacs in cross-section.<br />
<b>Figure B</b> shows fibrosis (scarring) in the lungs. The inset image shows a detailed view of the fibrosis and how it damages the airways and air sacs.<sup id="cite_ref-NIH_IPF_1-0" class="reference"><a href="#cite_note-NIH_IPF-1"><span>[</span>1<span>]</span></a></sup></div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/J84.1">J84.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=516.3">516.3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/178500">178500</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb4815.htm">4815</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000069.htm">000069</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/radio/topic873.htm">radio/873</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/idiopathic-pulmonary-fibrosis">Idiopathic pulmonary fibrosis</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D011658">D011658</a></td>
</tr>
</table>
<p><b>Idiopathic pulmonary fibrosis</b> (<b>IPF</b>) is a chronic and ultimately fatal disease characterized by a progressive decline in lung function.<sup id="cite_ref-RaghuCollard_2-0" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-0" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup> The term <a href="/wiki/Pulmonary_fibrosis" title="Pulmonary fibrosis">pulmonary fibrosis</a> means scarring of lung tissue and is the cause of worsening <a href="/wiki/Dyspnea" title="Dyspnea">dyspnea</a> (shortness of breath). <a href="/wiki/Fibrosis" title="Fibrosis">Fibrosis</a> is usually associated with a poor <a href="/wiki/Prognosis" title="Prognosis">prognosis</a>.<sup id="cite_ref-RaghuCollard_2-1" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-1" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-MeltzerNoble_4-0" class="reference"><a href="#cite_note-MeltzerNoble-4"><span>[</span>4<span>]</span></a></sup> The term '<a href="/wiki/Idiopathic" title="Idiopathic" class="mw-redirect">idiopathic</a>' is used because the cause of pulmonary fibrosis is still unknown.<sup id="cite_ref-RaghuCollard_2-2" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<p>IPF usually occurs in adult individuals of between 50 and 70 years of age, particularly those with a history of <a href="/wiki/Cigarette_smoking" title="Cigarette smoking" class="mw-redirect">cigarette smoking</a>, and affects more men than women.<sup id="cite_ref-RaghuCollard_2-3" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-PulmonaryFibrosis_5-0" class="reference"><a href="#cite_note-PulmonaryFibrosis-5"><span>[</span>5<span>]</span></a></sup></p>
<p>IPF belongs to a large group of more than 200 lung diseases known as <a href="/wiki/Interstitial_lung_disease" title="Interstitial lung disease">interstitial lung diseases</a> (ILD), characterized by the involvement of lung <a href="/wiki/Interstitium" title="Interstitium" class="mw-redirect">interstitium</a>.<sup id="cite_ref-ATS.2FERS_3-2" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup> The interstitium, the tissue between the <a href="/wiki/Alveoli" title="Alveoli" class="mw-redirect">air sacs in the lung</a>, is the primary site of injury in ILDs. However, these disorders frequently affect not only the <a href="/wiki/Interstitium" title="Interstitium" class="mw-redirect">interstitium</a>, but also the airspaces, peripheral airways, and vessels.<sup id="cite_ref-ATS.2FERS_3-3" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup> Lung tissue from people with IPF shows a characteristic histopathologic pattern known as <a href="/wiki/Usual_interstitial_pneumonia" title="Usual interstitial pneumonia">usual interstitial pneumonia</a> (UIP). UIP is therefore the pathologic counterpart of IPF.<sup id="cite_ref-RaghuCollard_2-4" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-PulmonaryFibrosis_5-1" class="reference"><a href="#cite_note-PulmonaryFibrosis-5"><span>[</span>5<span>]</span></a></sup></p>
<p>In 2011, new guidelines for the diagnosis and management of IPF were published.<sup id="cite_ref-RaghuCollard_2-5" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> The diagnosis of IPF requires exclusion of other known causes of ILD and the presence of a typical radiological pattern identified through <a href="/wiki/High_resolution_computed_tomography" title="High resolution computed tomography" class="mw-redirect">high resolution computed tomography</a> (HRCT). In the right clinical setting, it is possible to make the diagnosis of IPF by HRCT alone, obviating the need for surgical lung biopsy.<sup id="cite_ref-RaghuCollard_2-6" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-4" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Pathogenesis"><span class="tocnumber">4</span> <span class="toctext">Pathogenesis</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Radiology"><span class="tocnumber">5.1</span> <span class="toctext">Radiology</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Histology"><span class="tocnumber">5.2</span> <span class="toctext">Histology</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Bronchoalveolar_lavage"><span class="tocnumber">5.3</span> <span class="toctext">Bronchoalveolar lavage</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Pulmonary_function_tests"><span class="tocnumber">5.4</span> <span class="toctext">Pulmonary function tests</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-10"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#Pharmacologic_interventions"><span class="tocnumber">6.1</span> <span class="toctext">Pharmacologic interventions</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Non_pharmacological_interventions"><span class="tocnumber">6.2</span> <span class="toctext">Non pharmacological interventions</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Palliative_care"><span class="tocnumber">6.3</span> <span class="toctext">Palliative care</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-14"><a href="#Management_and_follow-up"><span class="tocnumber">7</span> <span class="toctext">Management and follow-up</span></a>
<ul>
<li class="toclevel-2 tocsection-15"><a href="#Acute_exacerbations"><span class="tocnumber">7.1</span> <span class="toctext">Acute exacerbations</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Prognosis"><span class="tocnumber">8</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#Epidemiology"><span class="tocnumber">9</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#In_other_species"><span class="tocnumber">10</span> <span class="toctext">In other species</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>IPF belongs to a large group of more than 200 lung diseases known as interstitial lung diseases which are characterized by the involvement of the lung <a href="/wiki/Interstitium" title="Interstitium" class="mw-redirect">interstitium</a>,<sup id="cite_ref-ATS.2FERS_3-5" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup> the tissue between the air sacs of the lung. IPF is one specific presentation of <a href="/wiki/Idiopathic_interstitial_pneumonia" title="Idiopathic interstitial pneumonia">idiopathic interstitial pneumonia</a> (IIP), which is in turn a type of ILD, also known as <a href="/wiki/Diffuse_parenchymal_lung_disease" title="Diffuse parenchymal lung disease" class="mw-redirect">diffuse parenchymal lung disease</a> (DPLD).</p>
<p>The 2002 <a href="/wiki/American_Thoracic_Society" title="American Thoracic Society">American Thoracic Society</a>/<a href="/wiki/European_Respiratory_Society" title="European Respiratory Society">European Respiratory Society</a> (ATS/ERS) classification of IIPs was updated in 2013.<sup id="cite_ref-ATS.2FERS_3-6" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup> In this new classification there are three main categories of IIPs: major IIPs, rare IIPs, and unclassifiable IIPs. The major IIPs are grouped into chronic fibrosing IPs (this includes IPF and <a href="/wiki/Non-specific_interstitial_pneumonia" title="Non-specific interstitial pneumonia">non-specific interstitial pneumonia</a> [NSIP]); smoking-related IPs (i.e. respiratory bronchiolitis–interstitial lung disease [RB-ILD] and <a href="/wiki/Desquamative_interstitial_pneumonia" title="Desquamative interstitial pneumonia">desquamative interstitial pneumonia</a> [DIP]); and acute/subacute IPs (i.e. <a href="/wiki/Cryptogenic_organizing_pneumonia" title="Cryptogenic organizing pneumonia" class="mw-redirect">cryptogenic organizing pneumonia</a> [COP] and <a href="/wiki/Acute_interstitial_pneumonia" title="Acute interstitial pneumonia" class="mw-redirect">acute interstitial pneumonia</a> [AIP].<sup id="cite_ref-ATS.2FERS_3-7" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup></p>
<p>The diagnosis of IIPs requires exclusion of known causes of ILD. Examples of ILD of known cause include <a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">hypersensitivity pneumonitis</a>, pulmonary <a href="/wiki/Langerhan%E2%80%99s_cell_histiocytosis" title="Langerhan’s cell histiocytosis" class="mw-redirect">Langerhan’s cell histiocytosis</a>, <a href="/wiki/Asbestosis" title="Asbestosis">asbestosis</a>, and <a href="/wiki/Collagen_vascular_disease" title="Collagen vascular disease" class="mw-redirect">collagen vascular disease</a>. However, these disorders frequently affect not only the interstitium, but also the airspaces, peripheral airways, and blood vessels.<sup id="cite_ref-ATS.2FERS_3-8" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup></p>
<p>In the following figure the new classification of IIPs is presented:</p>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diffuse_Parenchymal_Lung_Diseases.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/96/Diffuse_Parenchymal_Lung_Diseases.jpg/220px-Diffuse_Parenchymal_Lung_Diseases.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/96/Diffuse_Parenchymal_Lung_Diseases.jpg/330px-Diffuse_Parenchymal_Lung_Diseases.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/96/Diffuse_Parenchymal_Lung_Diseases.jpg/440px-Diffuse_Parenchymal_Lung_Diseases.jpg 2x" data-file-width="1080" data-file-height="720" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diffuse_Parenchymal_Lung_Diseases.jpg" class="internal" title="Enlarge"></a></div>
Modified from American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. (2013). Am Respir Crit Care Med. 188 (6): 733–748. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/24032382?dopt=Abstract">PMID 24032382</a>.</div>
</div>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=2" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Clubbing_of_fingers_in_IPF.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Clubbing_of_fingers_in_IPF.jpg/220px-Clubbing_of_fingers_in_IPF.jpg" width="220" height="146" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Clubbing_of_fingers_in_IPF.jpg/330px-Clubbing_of_fingers_in_IPF.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/8/87/Clubbing_of_fingers_in_IPF.jpg 2x" data-file-width="400" data-file-height="265" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Clubbing_of_fingers_in_IPF.jpg" class="internal" title="Enlarge"></a></div>
Clubbing of the fingers in idiopathic pulmonary fibrosis</div>
</div>
</div>
<p>In many patients, symptoms are present for a considerable time before diagnosis.<sup id="cite_ref-MeltzerNoble_4-1" class="reference"><a href="#cite_note-MeltzerNoble-4"><span>[</span>4<span>]</span></a></sup> The most common clinical features of IPF include the following:<sup id="cite_ref-RaghuCollard_2-7" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-9" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-FlahertyMumford_6-0" class="reference"><a href="#cite_note-FlahertyMumford-6"><span>[</span>6<span>]</span></a></sup></p>
<ul>
<li>Age over 50 years</li>
<li>Dry, non-productive cough on exertion</li>
<li>Progressive exertional dyspnea (shortness of breath with exercise)</li>
<li>Dry, inspiratory bibasilar “velcro-like” <a href="/wiki/Crackles" title="Crackles">crackles</a> on <a href="/wiki/Auscultation" title="Auscultation">auscultation</a> (a crackling sound in the lungs during inhalation similar to Velcro being torn apart slowly, heard with a stethoscope).<sup id="cite_ref-RaghuCollard_2-8" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-RaghuWeycker_7-0" class="reference"><a href="#cite_note-RaghuWeycker-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-CottinCordier_8-0" class="reference"><a href="#cite_note-CottinCordier-8"><span>[</span>8<span>]</span></a></sup></li>
<li>Clubbing of the digits, a disfigurement of the finger tips or toes (see image)</li>
<li>Abnormal <a href="/wiki/Pulmonary_function_test" title="Pulmonary function test" class="mw-redirect">pulmonary function test</a> results, with evidence of restriction and impaired gas exchange.</li>
</ul>
<p>These features are due to chronic <a href="/wiki/Oxygen_deficiency" title="Oxygen deficiency" class="mw-redirect">oxygen deficiency</a> in blood and can occur in a wide variety of other pulmonary disorders and not be specific for IPF. However, IPF should be considered in all patients with unexplained chronic exertional dyspnea who present with cough, inspiratory bibasilar crackles, or finger clubbing.<sup id="cite_ref-RaghuCollard_2-9" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Assessment of “velcro” crackles on lung auscultation is a practical way to improve the earlier diagnosis of IPF. Fine crackles are easily recognized by clinicians and are characteristic of IPF.<sup id="cite_ref-BaughnmanShipley_9-0" class="reference"><a href="#cite_note-BaughnmanShipley-9"><span>[</span>9<span>]</span></a></sup></p>
<table class="mbox-small" style="border:1px solid #aaa;background-color:#f9f9f9;">
<tr>
<td class="mbox-image">
<div class="center">
<div class="floatnone"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Gnome-mime-sound-openclipart.svg/50px-Gnome-mime-sound-openclipart.svg.png" width="50" height="50" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Gnome-mime-sound-openclipart.svg/75px-Gnome-mime-sound-openclipart.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/87/Gnome-mime-sound-openclipart.svg/100px-Gnome-mime-sound-openclipart.svg.png 2x" data-file-width="160" data-file-height="160" /></div>
</div>
</td>
<td class="mbox-text plainlist" style="line-height:1.1em">
<div class="haudio">
<div style="padding:4px 0"><a href="/wiki/File:IPF_Lung_Sound.ogg" title="File:IPF Lung Sound.ogg">IPF Lung Sound</a></div>
<div>
<div class="mediaContainer" style="position:relative;display:block;width:220px"><audio id="mwe_player_0" style="width:220px" poster="//en.wikipedia.org/static/1.26wmf13/resources/assets/file-type-icons/fileicon-ogg.png" controls="" preload="none" class="kskin" data-durationhint="31.373446712018" data-startoffset="0" data-mwtitle="IPF_Lung_Sound.ogg" data-mwprovider="wikimediacommons"><source src="//upload.wikimedia.org/wikipedia/commons/1/1b/IPF_Lung_Sound.ogg" type="audio/ogg; codecs=&quot;vorbis&quot;" data-title="Original Ogg file (98 kbps)" data-shorttitle="Ogg source" data-width="0" data-height="0" data-bandwidth="98299"></source>Sorry, your browser either has JavaScript disabled or does not have any supported player.<br />
You can <a href="//upload.wikimedia.org/wikipedia/commons/1/1b/IPF_Lung_Sound.ogg">download the clip</a> or <a href="https://www.mediawiki.org/wiki/Special:MyLanguage/Extension:TimedMediaHandler/Client_download">download a player</a> to play the clip in your browser.</audio></div>
</div>
<div class="description" style="padding:2px 0 0 0">velcro crackles on auscultation in a patient with IPF</div>
</div>
<hr /></td>
</tr>
<tr>
<td colspan="2" class="mbox-text" style="line-height:1.1em"><span><i>Problems playing this file? See <a href="/wiki/Wikipedia:Media_help" title="Wikipedia:Media help">media help</a>.</i></span></td>
</tr>
</table>
<p>If bilateral fine crackles are present throughout the inspiratory time and are persisting after several deep breaths, and if remaining present on several occasions several weeks apart in a subject aged ≥60 years, this should raise the suspicion of IPF and lead to consideration of an HRCT scan of the chest which is more sensitive than a <a href="/wiki/Chest_X-ray" title="Chest X-ray" class="mw-redirect">chest X-ray</a>.<sup id="cite_ref-CottinCordier_8-1" class="reference"><a href="#cite_note-CottinCordier-8"><span>[</span>8<span>]</span></a></sup> As crackles are not specific for IPF, they must prompt a thorough diagnostic process.<sup id="cite_ref-RaghuCollard_2-10" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=3" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The cause of IPF is unknown but certain environmental factors and exposures have been shown to increase the risk of getting IPF.<sup id="cite_ref-OlsonSwigris_10-0" class="reference"><a href="#cite_note-OlsonSwigris-10"><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Cigarette_smoking" title="Cigarette smoking" class="mw-redirect">Cigarette smoking</a> is the best recognized and most accepted risk factor for IPF, and increases the risk of IPF by about twofold.<sup id="cite_ref-OlsonSwigris_10-1" class="reference"><a href="#cite_note-OlsonSwigris-10"><span>[</span>10<span>]</span></a></sup> Other environmental and occupational exposures such as exposure to metal dust, wood dust, coal dust, silica, stone dust, biologic dusts coming from hay dust or mold spores or other agricultural products, and occupations related to farming/livestock have also been shown to increase the risk for IPF.<sup id="cite_ref-OlsonSwigris_10-2" class="reference"><a href="#cite_note-OlsonSwigris-10"><span>[</span>10<span>]</span></a></sup>There is some evidence that viral infections may be associated with idiopathic pulmonary fibrosis and other fibrotic lung diseases.<sup id="cite_ref-Williams_11-0" class="reference"><a href="#cite_note-Williams-11"><span>[</span>11<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathogenesis">Pathogenesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=4" title="Edit section: Pathogenesis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Despite extensive investigation, the cause of IPF remains unknown.<sup id="cite_ref-RaghuCollard_2-11" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> The fibrosis in IPF has been linked to cigarette smoking, environmental factors (e.g. occupational exposure to gases, smoke, chemicals or dusts), other medical conditions including <a href="/wiki/Gastroesophageal_reflux_disease" title="Gastroesophageal reflux disease">gastroesophageal reflux disease</a> (GERD), or to genetic predisposition (familial IPF). However, none of these is present in all people with IPF and therefore do not provide a completely satisfactory explanation for the disease.<sup id="cite_ref-RaghuCollard_2-12" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-GarciaBuendia_12-0" class="reference"><a href="#cite_note-GarciaBuendia-12"><span>[</span>12<span>]</span></a></sup></p>
<p>IPF is believed to be the result of an aberrant wound healing process including/involving abnormal and excessive deposition of <a href="/wiki/Collagen" title="Collagen">collagen</a> (fibrosis) in the pulmonary <a href="/wiki/Interstitium" title="Interstitium" class="mw-redirect">interstitium</a> with minimal associated <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>.<sup id="cite_ref-HarariCaminati_13-0" class="reference"><a href="#cite_note-HarariCaminati-13"><span>[</span>13<span>]</span></a></sup></p>
<p>It is hypothesized that the initial or repetitive injury in IPF occurs to the lung cells, called alveolar epithelial cells (AECs, pneumocytes), which line the majority of the alveolar surface.<sup id="cite_ref-LoomisFlaherty_14-0" class="reference"><a href="#cite_note-LoomisFlaherty-14"><span>[</span>14<span>]</span></a></sup> When type I AECs are damaged or lost, it is thought that type II AECs undergo proliferation to cover the exposed basement membranes. In normal repair, the hyperplastic type II AECs die and the remaining cells spread and undergo a differentiation process to become type I AECs. Under pathologic conditions and in the presence of <a href="/wiki/Transforming_growth_factor_beta" title="Transforming growth factor beta">transforming growth factor beta</a> (TGFβ), <a href="/wiki/Fibroblasts" title="Fibroblasts" class="mw-redirect">fibroblasts</a> accumulate in these areas of damage and differentiate into <a href="/wiki/Myofibroblasts" title="Myofibroblasts" class="mw-redirect">myofibroblasts</a> that secrete collagen and other proteins.<sup id="cite_ref-LoomisFlaherty_14-1" class="reference"><a href="#cite_note-LoomisFlaherty-14"><span>[</span>14<span>]</span></a></sup> In the past, It was thought that <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> was the first event in initiating lung tissue scarring. According to the most recent findings, however, the development of fibroblastic foci precedes the accumulation of inflammatory cells and the consequent deposition of collagen.<sup id="cite_ref-PardoSelman_15-0" class="reference"><a href="#cite_note-PardoSelman-15"><span>[</span>15<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Concepts_of_IPF.jpg" class="image"><img alt="Etiology and pathobiology of Idiopathic Pulmonary Fibrosis (IPF)" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Concepts_of_IPF.jpg/220px-Concepts_of_IPF.jpg" width="220" height="140" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/8/87/Concepts_of_IPF.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/8/87/Concepts_of_IPF.jpg 2x" data-file-width="285" data-file-height="182" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Concepts_of_IPF.jpg" class="internal" title="Enlarge"></a></div>
</div>
</div>
</div>
<p>This pathogenetic model is indirectly supported by the clinical features of IPF, including an insidious onset, progression over several years, relatively infrequent acute exacerbations, and failure to respond to <a href="/wiki/Immunosuppressive_therapy" title="Immunosuppressive therapy" class="mw-redirect">immunosuppressive therapy</a>.<sup id="cite_ref-HarariCaminati_13-1" class="reference"><a href="#cite_note-HarariCaminati-13"><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-SelmanKing_16-0" class="reference"><a href="#cite_note-SelmanKing-16"><span>[</span>16<span>]</span></a></sup> A number of therapies that target fibroblast activation or the synthesis of extracellular matrix are currently in early testing or are being considered for development.</p>
<p>Familial IPF accounts for less than 5% of the total of patients with IPF and is clinically and histologically indistinguishable from sporadic IPF.<sup id="cite_ref-RaghuCollard_2-13" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> Genetic associations include mutations in <a href="/wiki/Pulmonary_surfactant" title="Pulmonary surfactant">pulmonary surfactant</a> proteins A1, A2, C (<a href="/wiki/SFTPA1" title="SFTPA1" class="mw-redirect">SFTPA1</a>, <a href="/wiki/SFTPA2B" title="SFTPA2B" class="mw-redirect">SFTPA2B</a>) and <a href="/wiki/Mucin" title="Mucin">mucin</a> (<a href="/wiki/MUC5B" title="MUC5B">MUC5B</a>).<sup id="cite_ref-OMIM_17-0" class="reference"><a href="#cite_note-OMIM-17"><span>[</span>17<span>]</span></a></sup> A remarkable aspect of the MUC5B variant is its high frequency of detection, as it is found in approximately 20% of individuals with Northern and Western European ancestry and in 19% of the Framingham Heart Study population.<sup id="cite_ref-Mathai_18-0" class="reference"><a href="#cite_note-Mathai-18"><span>[</span>18<span>]</span></a></sup> Mutations in human <a href="/wiki/Telomerase" title="Telomerase">telomerase</a> genes are also associated with familial pulmonary fibrosis and in some patients with sporadic IPF (e.g. the <a href="/wiki/TERT" title="TERT" class="mw-redirect">TERT</a>, <a href="/wiki/TERC" title="TERC" class="mw-disambig">TERC</a> genes).<sup id="cite_ref-OMIM_17-1" class="reference"><a href="#cite_note-OMIM-17"><span>[</span>17<span>]</span></a></sup> Recently an X-linked mutation in a third telomerase-associated gene, dyskerin (DKC1), has been described in a family with IPF.<sup id="cite_ref-KropskiMitchell_19-0" class="reference"><a href="#cite_note-KropskiMitchell-19"><span>[</span>19<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=5" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>An earlier diagnosis of IPF is a prerequisite for earlier treatment and, potentially, improvement of the long-term clinical outcome of this progressive and ultimately fatal disease.<sup id="cite_ref-RaghuCollard_2-14" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> If IPF is suspected, diagnosis can be challenging but a multidisciplinary approach involving a pulmonologist, radiologist and pathologist expert in interstitial lung disease has been shown to improve the accuracy of IPF diagnosis.<sup id="cite_ref-RaghuCollard_2-15" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-FlahertyKing_20-0" class="reference"><a href="#cite_note-FlahertyKing-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-FlahertyAndrei_21-0" class="reference"><a href="#cite_note-FlahertyAndrei-21"><span>[</span>21<span>]</span></a></sup></p>
<p>A Multidisciplinary Consensus Statement on the Idiopathic Interstitial Pneumonias published by the <a href="/wiki/American_Thoracic_Society" title="American Thoracic Society">American Thoracic Society</a> (ATS) and the <a href="/wiki/European_Respiratory_Society" title="European Respiratory Society">European Respiratory Society</a> (ERS) in 2000 proposed specific major and minor criteria for establishing the diagnosis of IPF.<sup id="cite_ref-RaghuCollard_2-16" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> However, in 2011, new simplified and updated criteria for the diagnosis and management of IPF were published by the ATS, ERS, together with the Japanese Respiratory Society (JRS) and Latin American Thoracic Association (ALAT).<sup id="cite_ref-RaghuCollard_2-17" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> Currently, a diagnosis of IPF requires:</p>
<ul>
<li>Exclusion of known causes of ILD, e.g., domestic and occupational environmental exposures, connective tissue disorders, or drug exposure/toxicity</li>
<li>The presence of a typical radiological UIP pattern on HRCT.</li>
</ul>
<p>In the right clinical setting, it is possible to make the diagnosis of IPF by HRCT alone, obviating the need for surgical lung biopsy.<sup id="cite_ref-RaghuCollard_2-18" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-10" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Recognizing IPF in clinical practice can be challenging as <a href="/wiki/Symptoms" title="Symptoms" class="mw-redirect">symptoms</a> often appear similar to those of more common diseases, such <a href="/wiki/Asthma" title="Asthma">asthma</a>, <a href="/wiki/Chronic_obstructive_pulmonary_disease" title="Chronic obstructive pulmonary disease">chronic obstructive pulmonary disease</a> (COPD) and <a href="/wiki/Congestive_heart_failure" title="Congestive heart failure" class="mw-redirect">congestive heart failure</a> (<a rel="nofollow" class="external text" href="http://www.diagnoseipf.com">www.diagnoseipf.com</a>). The key issue facing clinicians is whether the presenting history, <a href="/wiki/Symptoms" title="Symptoms" class="mw-redirect">symptoms</a> (or signs), <a href="/wiki/Radiology" title="Radiology">radiology</a>, and <a href="/wiki/Pulmonary_function_testing" title="Pulmonary function testing">pulmonary function testing</a> are collectively in keeping with the diagnosis of IPF or whether the findings are due to another process. It has long been recognized that patients with ILD related to <a href="/wiki/Asbestos" title="Asbestos">asbestos</a> exposure, <a href="/wiki/Drugs" title="Drugs" class="mw-redirect">drugs</a> (such as <a href="/wiki/Chemotherapeutic" title="Chemotherapeutic" class="mw-redirect">chemotherapeutic</a> agents or <a href="/wiki/Nitrofurantoin" title="Nitrofurantoin">nitrofurantoin</a>), <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a> and <a href="/wiki/Scleroderma" title="Scleroderma">scleroderma</a>/<a href="/wiki/Systemic_sclerosis" title="Systemic sclerosis" class="mw-redirect">systemic sclerosis</a> may be difficult to distinguish from IPF. Other differential diagnostic considerations include interstitial lung disease related to <a href="/wiki/Mixed_connective_tissue_disease" title="Mixed connective tissue disease">mixed connective tissue disease</a>, advanced <a href="/wiki/Sarcoidosis" title="Sarcoidosis">sarcoidosis</a>, chronic <a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">hypersensitivity pneumonitis</a>, pulmonary <a href="/wiki/Langerhan%E2%80%99s_cell_histiocytosis" title="Langerhan’s cell histiocytosis" class="mw-redirect">Langerhan’s cell histiocytosis</a> and <a href="/wiki/Radiation-induced_lung_injury" title="Radiation-induced lung injury">radiation-induced lung injury</a>.<sup id="cite_ref-RaghuCollard_2-19" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-11" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Radiology">Radiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=6" title="Edit section: Radiology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Chest_X-rays" title="Chest X-rays" class="mw-redirect">Chest X-rays</a> are useful in the follow up routine of IPF patients. Plain chest X-rays are unfortunately not diagnostic but may reveal decreased <a href="/wiki/Lung_volumes" title="Lung volumes">lung volumes</a>, typically with prominent reticular interstitial markings near the lung bases.<sup id="cite_ref-RaghuCollard_2-20" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Radiological_evaluation_through_HRCT.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/17/Radiological_evaluation_through_HRCT.jpg/220px-Radiological_evaluation_through_HRCT.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/17/Radiological_evaluation_through_HRCT.jpg/330px-Radiological_evaluation_through_HRCT.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/17/Radiological_evaluation_through_HRCT.jpg/440px-Radiological_evaluation_through_HRCT.jpg 2x" data-file-width="1160" data-file-height="774" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Radiological_evaluation_through_HRCT.jpg" class="internal" title="Enlarge"></a></div>
A chest radiograph of a patient with IPF. Note the small lung fields and peripheral pattern of reticulonodular opacification.</div>
</div>
</div>
<p>The radiological evaluation through HRCT is an essential point in the diagnostic pathway in IPF. HRCT is performed using a conventional <a href="/wiki/X-ray_computed_tomography" title="X-ray computed tomography" class="mw-redirect">computed axial tomographic scanner</a> without injection of contrast agents. Evaluation slices are very thin, 1–2&#160;mm.</p>
<p>Typical HRCT of the chest of IPF demonstrates fibrotic changes in both lungs, with a predilection for the bases and the periphery. According to the joint ATS/ERS/JRS/ALAT 2011 guidelines, HRCT is an essential component of the diagnostic pathway in IPF which can identify UIP by the presence of:<sup id="cite_ref-RaghuCollard_2-21" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<ul>
<li>Reticular opacities, often associated with <a href="/wiki/Traction_bronchiectasis" title="Traction bronchiectasis" class="mw-redirect">traction bronchiectasis</a></li>
<li><a href="/wiki/Honeycombing" title="Honeycombing">Honeycombing</a> manifested as cluster cystic airspaces, typically of comparable diameters (3–10&#160;mm) but occasionally large. Usually sub-pleural and characterized by well-defined walls and disposed in at least two lines. Generally one line of cysts is not sufficient to define honeycombing</li>
<li><a href="/wiki/Ground-glass_opacities" title="Ground-glass opacities" class="mw-redirect">Ground-glass opacities</a> are common but less extensive than the reticulation</li>
<li>Distribution characteristically basal and peripheral though often patchy.</li>
</ul>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:422px;"><a href="/wiki/File:HR_tomography_of_the_chest_of_an_IPF_patient.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/8/82/HR_tomography_of_the_chest_of_an_IPF_patient.jpg" width="420" height="184" class="thumbimage" data-file-width="420" data-file-height="184" /></a>
<div class="thumbcaption">High-resolution computed tomography scans of the chest of a patient with IPF. The main features are of a peripheral, predominantly basal pattern of coarse reticulation with honeycombing</div>
</div>
</div>
</div>
<h3><span class="mw-headline" id="Histology">Histology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=7" title="Edit section: Histology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>According to the updated 2011 guidelines, in the absence of a typical UIP pattern on HRCT, a surgical lung biopsy is required for confident diagnosis.<sup id="cite_ref-RaghuCollard_2-22" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Histologic specimens for the diagnosis of IPF must be taken at least in three different places and be large enough that the pathologist can comment on the underlying lung architecture. Small biopsies, such as those obtained via transbronchial lung <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> (performed during bronchoscopy) are usually not sufficient for this purpose. Hence, larger biopsies obtained surgically via a <a href="/wiki/Thoracotomy" title="Thoracotomy">thoracotomy</a> or <a href="/wiki/Thoracoscopy" title="Thoracoscopy">thoracoscopy</a> are usually necessary.<sup id="cite_ref-RaghuCollard_2-23" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-ATS.2FERS_3-12" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Lung tissue from people with IPF usually show a characteristic histopathologic UIP pattern and is therefore the pathologic counterpart of IPF.<sup id="cite_ref-RaghuCollard_2-24" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-PulmonaryFibrosis_5-2" class="reference"><a href="#cite_note-PulmonaryFibrosis-5"><span>[</span>5<span>]</span></a></sup> Although a pathologic diagnosis of UIP often corresponds to a clinical diagnosis of IPF, a UIP histologic pattern can be seen in other diseases as well, and fibrosis of known origin (rheumatic diseases for example).<sup id="cite_ref-NIH_IPF_1-1" class="reference"><a href="#cite_note-NIH_IPF-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-RaghuCollard_2-25" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> There are four key features of UIP including interstitial fibrosis in a ‘patchwork pattern’, interstitial scarring, honeycomb changes and fibroblast foci.</p>
<p>Fibroblastic foci are dense collections of myofibroblasts and scar tissue and, together with honeycombing, are the main pathological findings that allow a diagnosis of UIP.</p>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:550px;"><a href="/wiki/File:Photomicrograph_of_usual_interstitial_pneumonia.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/5/56/Photomicrograph_of_usual_interstitial_pneumonia.jpg" width="548" height="221" class="thumbimage" data-file-width="548" data-file-height="221" /></a>
<div class="thumbcaption">Photomicrograph of the histopathological appearances of usual interstitial pneumonia. High-power magnification (on the right) shows a focus of fibroblastic proliferation, close to an area of fibrosis within which a mild, non-specific, chronic inflammatory cell infiltrate can be observed. In the subpleural space, a typical honeycombing aspect can be recognized.</div>
</div>
</div>
</div>
<h3><span class="mw-headline" id="Bronchoalveolar_lavage">Bronchoalveolar lavage</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=8" title="Edit section: Bronchoalveolar lavage">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Bronchoalveolar_lavage" title="Bronchoalveolar lavage">Bronchoalveolar lavage</a> (BAL) is a well-tolerated diagnostic procedure in ILD.<sup id="cite_ref-FlahertyMumford_6-1" class="reference"><a href="#cite_note-FlahertyMumford-6"><span>[</span>6<span>]</span></a></sup> BAL cytology analyses (differential cell counts) should be considered in the evaluation of patients with IPF at the discretion of the treating physician based on availability and experience at their institution. BAL may reveal alternative specific diagnoses: <a href="/wiki/Malignancy" title="Malignancy">malignancy</a>, <a href="/wiki/Infections" title="Infections" class="mw-redirect">infections</a>, <a href="/wiki/Eosinophilic_pneumonia" title="Eosinophilic pneumonia">eosinophilic pneumonia</a>, <a href="/wiki/Histiocytosis_X" title="Histiocytosis X" class="mw-redirect">histiocytosis X</a>, or <a href="/wiki/Alveolar_proteinosis" title="Alveolar proteinosis" class="mw-redirect">alveolar proteinosis</a>. In the evaluation of patients with suspected IPF, the most important application of BAL is in the exclusion of other diagnoses. Prominent <a href="/wiki/Lymphocytosis" title="Lymphocytosis">lymphocytosis</a> (&gt;30%) generally allows excluding a diagnosis of IPF.<sup id="cite_ref-OhshimoBonella_22-0" class="reference"><a href="#cite_note-OhshimoBonella-22"><span>[</span>22<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Pulmonary_function_tests">Pulmonary function tests</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=9" title="Edit section: Pulmonary function tests">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Spirometry" title="Spirometry">Spirometry</a> classically reveals a reduction in the <a href="/wiki/Vital_capacity" title="Vital capacity">vital capacity</a> (VC) with either a proportionate reduction in airflows, or increased airflows for the observed vital capacity. The latter finding reflects the increased lung stiffness (reduced lung compliance) associated with pulmonary fibrosis, which leads to increased lung elastic recoil.<sup id="cite_ref-PellegrinoViegi_23-0" class="reference"><a href="#cite_note-PellegrinoViegi-23"><span>[</span>23<span>]</span></a></sup></p>
<p>Measurement of static lung volumes using <a href="/wiki/Body_plethysmography" title="Body plethysmography" class="mw-redirect">body plethysmography</a> or other techniques typically reveals reduced lung volumes (restriction). This reflects the difficulty encountered in inflating the fibrotic lungs.</p>
<p>The diffusing capacity for carbon monoxide (DL<small>CO</small>) is invariably reduced in IPF and may be the only abnormality in mild or early disease. Its impairment underlies the propensity of patients with IPF to exhibit oxygen desaturation with exercise which can also be evaluated using the 6-minute walk test (6MWT).<sup id="cite_ref-RaghuCollard_2-26" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Terms such as ‘mild’, ‘moderate’, and ‘severe’ are sometimes used for staging disease and are commonly based on resting pulmonary function test measurements.<sup id="cite_ref-RaghuCollard_2-27" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> However, there is no clear consensus regarding the staging of IPF patients and what are the best criteria and values to use. Mild-to-moderate IPF has been characterized by the following functional criteria:<sup id="cite_ref-NobleAlbera_24-0" class="reference"><a href="#cite_note-NobleAlbera-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-MartinezSafrin_25-0" class="reference"><a href="#cite_note-MartinezSafrin-25"><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-KingBradford_26-0" class="reference"><a href="#cite_note-KingBradford-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-RicheldiduBois_27-0" class="reference"><a href="#cite_note-RicheldiduBois-27"><span>[</span>27<span>]</span></a></sup></p>
<ul>
<li>Forced Vital Capacity (FVC) of ≥50%</li>
<li>DL<small>CO</small> of ≥30%</li>
<li>6MWT distance ≥150 meters.</li>
</ul>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=10" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The goals of treatment in IPF are essentially to reduce the symptoms, stop disease progression, prevent acute exacerbations, and prolong survival. Preventive care (e.g. vaccinations) and symptom-based treatment should be started early in every patient.<sup id="cite_ref-LeeMcLaughlin_28-0" class="reference"><a href="#cite_note-LeeMcLaughlin-28"><span>[</span>28<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Pharmacologic_interventions">Pharmacologic interventions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=11" title="Edit section: Pharmacologic interventions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A number of treatments have been investigated in the past for IPF, including <a href="/wiki/Interferon_beta_1a" title="Interferon beta 1a">interferon gamma-1β</a>,<sup id="cite_ref-KingAlberaBradford_29-0" class="reference"><a href="#cite_note-KingAlberaBradford-29"><span>[</span>29<span>]</span></a></sup> <a href="/wiki/Bosentan" title="Bosentan">bosentan</a>,<sup id="cite_ref-KingBrown_30-0" class="reference"><a href="#cite_note-KingBrown-30"><span>[</span>30<span>]</span></a></sup> <a href="/wiki/Ambrisentan" title="Ambrisentan">ambrisentan</a>,<sup id="cite_ref-RaghuBehr_31-0" class="reference"><a href="#cite_note-RaghuBehr-31"><span>[</span>31<span>]</span></a></sup> and <a href="/wiki/Anticoagulants" title="Anticoagulants" class="mw-redirect">anticoagulants</a>,<sup id="cite_ref-NothAnstrom_32-0" class="reference"><a href="#cite_note-NothAnstrom-32"><span>[</span>32<span>]</span></a></sup> but these are no longer considered effective treatment options. Many of these earlier studies were based on the hypothesis that IPF is an inflammatory disorder.</p>
<dl>
<dt>Pirfenidone</dt>
</dl>
<p><a href="/wiki/Pirfenidone" title="Pirfenidone">Pirfenidone</a> is a small molecule that combines both anti-inflammatory, anti-oxidant, and anti-fibrotic effects in experimental models of fibrosis.<sup id="cite_ref-SchaeferRuhrmund_33-0" class="reference"><a href="#cite_note-SchaeferRuhrmund-33"><span>[</span>33<span>]</span></a></sup> Pirfenidone marketed under the trade name <a rel="nofollow" class="external text" href="http://www.intermune.com/pirfenidone">Esbriet®</a>, is approved in Europe for the treatment of patients with mild-to-modetate IPF. It is also approved in Japan and South Korea (trade name Pirespa®), as well as in Canada, China, India, Argentina and Mexico. In October 2014 it was approved for use in IPF in the United States of America by the Food and Drug Administration (FDA).<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<p>Pirfenidone was approved in the European Union based on the results of three Phase III, randomized, double-blind, placebo-controlled studies, one conducted in Japan and the other two in Europe and the USA (<a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/21571362">CAPACITY</a> trials).<sup id="cite_ref-NobleAlbera_24-1" class="reference"><a href="#cite_note-NobleAlbera-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-TaniguchiEbina_35-0" class="reference"><a href="#cite_note-TaniguchiEbina-35"><span>[</span>35<span>]</span></a></sup></p>
<p>A Review on the <a href="/wiki/Cochrane_Library" title="Cochrane Library">Cochrane Library</a> (the journal of the Cochrane Collaboration for evidence-based Medicine) based on four trials involving 1155 patients comparing pirfenidone with placebo, demonstrated a significantly reduced risk of disease progression in patients treated with pirfenidone by 30%.<sup id="cite_ref-SpagnoloDelGiovane_36-0" class="reference"><a href="#cite_note-SpagnoloDelGiovane-36"><span>[</span>36<span>]</span></a></sup> FVC or VC was also significantly improved by pirfenidone, even if a mild slowing in FVC decline could be demonstrated only in one of the two CAPACITY trials.<sup id="cite_ref-NobleAlbera_24-2" class="reference"><a href="#cite_note-NobleAlbera-24"><span>[</span>24<span>]</span></a></sup> On the basis of these mixed results, the American Federal <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) requested a third multinational Phase III clinical study, <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/24836312">ASCEND</a> (NCT01366209). This study, which was completed in 2014 and published on-line in the New England Journal of Medicine, showed that pirfenidone significantly reduced decline in lung function and IPF disease progression.<sup id="cite_ref-KingBradford_26-1" class="reference"><a href="#cite_note-KingBradford-26"><span>[</span>26<span>]</span></a></sup> The data from the ASCEND study were also pooled with data from the two CAPACITY studies in a pre-specified analysis which showed that pirfenidone reduced the risk of death by almost 50% over one year of treatment.<sup id="cite_ref-KingBradford_26-2" class="reference"><a href="#cite_note-KingBradford-26"><span>[</span>26<span>]</span></a></sup> Based on these results, pirfenidone has been granted Breakthrough Therapy Designation from the U.S. FDA, a designation reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints.<sup id="cite_ref-IntermunePress_37-0" class="reference"><a href="#cite_note-IntermunePress-37"><span>[</span>37<span>]</span></a></sup> The company that has developed pirfenidone, InterMune Inc., is providing compassionate use of pirfenidone through a multi-center Expanded Access Program (EAP) in the United States during the pre-approval period.<sup id="cite_ref-IntermuneAnnounces_38-0" class="reference"><a href="#cite_note-IntermuneAnnounces-38"><span>[</span>38<span>]</span></a></sup></p>
<dl>
<dt>N-acetylcysteine and triple therapy</dt>
</dl>
<p><a href="/wiki/N-Acetylcysteine" title="N-Acetylcysteine" class="mw-redirect"><i>N</i>-Acetylcysteine</a> (NAC) is a precursor to glutathione, an <a href="/wiki/Antioxidant" title="Antioxidant">antioxidant</a>. It has been hypothesized that treatment with high doses of NAC may repair an oxidant–antioxidant imbalance that occurs in the lung tissue of patients with IPF. In the first clinical trial of 180 patients (IFIGENIA), NAC was shown in previous study to reduce the decline in VC and DLCO over 12 months of follow-up when used in combination with <a href="/wiki/Prednisone" title="Prednisone">prednisone</a> and <a href="/wiki/Azathioprine" title="Azathioprine">azathioprine</a> (triple therapy).<sup id="cite_ref-DemedtsBehr_39-0" class="reference"><a href="#cite_note-DemedtsBehr-39"><span>[</span>39<span>]</span></a></sup></p>
<p>More recently, a large randomized, controlled trial (PANTHER-IPF) was undertaken by the <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">National Institutes of Health</a> (NIH) in the USA to evaluate triple therapy and NAC monotherapy in IPF patients. This study found that the combination of prednisone, azathioprine, and NAC increased the risk of death and hospitalizations<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup> and the NIH announced in 2012 that the triple-therapy arm of the PANTHER-IPF study had been terminated early.<sup id="cite_ref-NIHApril2013_41-0" class="reference"><a href="#cite_note-NIHApril2013-41"><span>[</span>41<span>]</span></a></sup></p>
<p>This study also evaluated NAC alone and the results for this arm of the study were published in May 2014 in the New England Journal of Medicine, concluding that "as compared with placebo, acetylcysteine offered no significant benefit with respect to the preservation of FVC in patients with idiopathic pulmonary fibrosis with mild-to-moderate impairment in lung function".<sup id="cite_ref-IPFCRN_42-0" class="reference"><a href="#cite_note-IPFCRN-42"><span>[</span>42<span>]</span></a></sup></p>
<dl>
<dt>Nintedanib (formerly BIBF 1120)</dt>
</dl>
<p>One treatment in development has completed two Phase III trials (INPULSIS-1 and INPULSIS-2).<sup id="cite_ref-RicheldiduBois_27-1" class="reference"><a href="#cite_note-RicheldiduBois-27"><span>[</span>27<span>]</span></a></sup> Nintedanib is an investigational orally-administered triple angiokinase inhibitor that targets receptor tyrosine kinases involved in the regulation of angiogenesis: fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR), and vascular endothelial growth factor receptor (VEGFR),<sup id="cite_ref-BIBF_43-0" class="reference"><a href="#cite_note-BIBF-43"><span>[</span>43<span>]</span></a></sup> which have also been implicated in the pathogenesis of fibrosis and IPF. In both phase III trials, nintedanib significantly reduced the decline in lung function by approximately 50% over one year.<sup id="cite_ref-RicheldiduBois_27-2" class="reference"><a href="#cite_note-RicheldiduBois-27"><span>[</span>27<span>]</span></a></sup></p>
<p>With regards to the secondary endpoints, only in INPULSIS-2 trial, there was a significant increase in the time (delayed onset) of the first acute exacerbation (seeabove) in the nintedanib group as compared with the placebo group. In INPULSIS-1 trial this increase was not seen.</p>
<p>Nintedanib, like pirfenidone, was approved for the treatment of Idiopathic Pulmonary Fibrosis by the U.S. FDA in October 2014.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></p>
<dl>
<dt>Future therapeutic options</dt>
</dl>
<p>A number of agents are currently being investigated in Phase II clinical trials for IPF, including the monoclonal antibodies simtuzumab, tralokimab, lebrikizumab and FG-3019, a lysophosphatidic acid receptor antagonist (BMS-986020). A Phase II study of STX-100 is also ongoing.<sup id="cite_ref-CoalitionForPF_45-0" class="reference"><a href="#cite_note-CoalitionForPF-45"><span>[</span>45<span>]</span></a></sup> These molecules are directed against several growth factors and cytokines that are known to play a role in the proliferation, activation, differentiation or inappropriate survival of fibroblasts.</p>
<p>More information can be found at <a rel="nofollow" class="external text" href="http://ClinicalTrials.gov">ClinicalTrials.gov</a>, a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.</p>
<h3><span class="mw-headline" id="Non_pharmacological_interventions">Non pharmacological interventions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=12" title="Edit section: Non pharmacological interventions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<dl>
<dt>Lung transplantation</dt>
</dl>
<p><a href="/wiki/Lung_transplantation" title="Lung transplantation">Lung transplantation</a> may be suitable for those patients physically eligible to undergo a major transplant operation. In IPF patients, lung transplant has been shown to reduce the risk of death by 75% as compared with patients who remain on the waiting list.<sup id="cite_ref-RussoIribarne_46-0" class="reference"><a href="#cite_note-RussoIribarne-46"><span>[</span>46<span>]</span></a></sup> Since the introduction of the <a href="/wiki/Lung_allocation_score" title="Lung allocation score">lung allocation score</a> (LAS), which prioritizes transplant candidates based on survival probability, IPF has become the most common indication for lung transplantation in the USA.<sup id="cite_ref-SpagnoloTonelli_47-0" class="reference"><a href="#cite_note-SpagnoloTonelli-47"><span>[</span>47<span>]</span></a></sup></p>
<p>Symptomatic patients with IPF younger than 65 years of age and with a body mass index (BMI) ≤26&#160;kg/m<sup>2</sup> should be referred for lung transplantation, but there are no clear data to guide the precise timing for LTx. Although controversial, the most recent data suggest that bilateral lung transplantation is superior to single lung transplantation in patients with IPF.<sup id="cite_ref-GeorgeArnaoutakis_48-0" class="reference"><a href="#cite_note-GeorgeArnaoutakis-48"><span>[</span>48<span>]</span></a></sup> Five-year survival rates after lung transplantation in IPF are estimated at between 50 to 56%.<sup id="cite_ref-RaghuCollard_2-28" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-MasonBrizzio_49-0" class="reference"><a href="#cite_note-MasonBrizzio-49"><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-KeatingLevvey_50-0" class="reference"><a href="#cite_note-KeatingLevvey-50"><span>[</span>50<span>]</span></a></sup></p>
<dl>
<dt>Long-term oxygen therapy (LTOT)</dt>
</dl>
<p>In the 2011 IPF guidelines, <a href="/wiki/Oxygen_therapy" title="Oxygen therapy">oxygen therapy</a>, or supplementary oxygen for home use, became a strong recommendation for use in those patients with clinically significant resting hypoxemia. Although oxygen therapy has not been shown to improve survival in IPF, some data indicate an improvement in exercise capacity.<sup id="cite_ref-RaghuCollard_2-29" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-MorrisonStovall_51-0" class="reference"><a href="#cite_note-MorrisonStovall-51"><span>[</span>51<span>]</span></a></sup></p>
<dl>
<dt>Pulmonary rehabilitation</dt>
</dl>
<p>Fatigue and loss of muscular mass are common and disabling problems for patients with IPF. <a href="/wiki/Pulmonary_rehabilitation" title="Pulmonary rehabilitation">Pulmonary rehabilitation</a> may alleviate the overt symptoms of IPF and improve functional status by stabilizing and/or reversing the extrapulmonary features of the disease.<sup id="cite_ref-SpagnoloTonelli_47-1" class="reference"><a href="#cite_note-SpagnoloTonelli-47"><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-Lee_52-0" class="reference"><a href="#cite_note-Lee-52"><span>[</span>52<span>]</span></a></sup> The number of published studies on the role of pulmonary rehabilitation in idiopathic pulmonary fibrosis is small, but most of these studies have found significant short-term improvements in functional exercise tolerance, quality of life, and dyspnea on exertion.<sup id="cite_ref-KennGloeckl_53-0" class="reference"><a href="#cite_note-KennGloeckl-53"><span>[</span>53<span>]</span></a></sup> Typical programs of rehabilitation include exercise training, nutritional modulation, occupational therapy, education and psychosocial counseling. In the late phase of disease, IPF patients tend to discontinue physical activity due to increasing dyspnea. Whenever possible, this should be discouraged.</p>
<h3><span class="mw-headline" id="Palliative_care">Palliative care</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=13" title="Edit section: Palliative care">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a> focuses on reducing symptoms and improving the comfort of patients rather than treating the disease. This may include treatment of worsening symptoms with the use of chronic <a href="/wiki/Opioids" title="Opioids" class="mw-redirect">opioids</a> for severe dyspnea and cough. Further, oxygen therapy may be useful for palliation of dyspnea in hypoxemic patients.</p>
<p>Palliative care also includes relief of physical and emotional suffering and psychosocial support for patients and caregivers.<sup id="cite_ref-RaghuCollard_2-30" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> With disease progression, patients may experience fear, anxiety and depression and psychological counseling should therefore be considered. In a recent study of outpatients with ILDs, including IPF, depression score, functional status (as assessed by walk test), as well as pulmonary function, all contributed to the severity of dyspnea.<sup id="cite_ref-RyersonBerkeley_54-0" class="reference"><a href="#cite_note-RyersonBerkeley-54"><span>[</span>54<span>]</span></a></sup></p>
<p>In selected cases of particularly severe dyspnea <a href="/wiki/Morphine" title="Morphine">morphine</a> could be considered. It can reduce dyspnea, anxiety and cough without significant decrease in oxygen saturation.<sup id="cite_ref-AllenRaut_55-0" class="reference"><a href="#cite_note-AllenRaut-55"><span>[</span>55<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management_and_follow-up">Management and follow-up</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=14" title="Edit section: Management and follow-up">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>IPF is often misdiagnosed, at least until physiological and/or imaging data suggest the presence of an ILD leading to delay in accessing appropriate care.<sup id="cite_ref-SpagnoloTonelli_47-2" class="reference"><a href="#cite_note-SpagnoloTonelli-47"><span>[</span>47<span>]</span></a></sup> Considering that IPF is a disease with a median survival of three years after diagnosis, early referral to a center with specific expertise should therefore be considered for any patient with suspected or known ILD. On the basis of the complex differential diagnostic, multidisciplinary discussion between pulmonologists, radiologists, and pathologists experienced in the diagnosis of ILD is of the utmost importance to an accurate diagnosis.<sup id="cite_ref-RaghuCollard_2-31" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<p>After diagnosis of IPF, and the appropriate treatment choice according to symptoms and stage of disease, a close follow-up should be applied. Due to the high variable course of disease, the higher incidence of complications such as lung cancer (up to 25% of patients has been reported in IPF) a routine evaluation every 3 to 6 months, including spirometry (body plethysmography), diffusion capacity testing, chest X-rays, 6MWT, assessment of dyspnea, quality of life, oxygen requirement is mandatory.</p>
<p>In addition, the increasing awareness of complications and common concomitant conditions frequently associated with IPF requires a routinely evaluation of comorbidities, most of them simply reflecting concurrent diseases of aging, and medications with their interaction and side effects.</p>
<h3><span class="mw-headline" id="Acute_exacerbations">Acute exacerbations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=15" title="Edit section: Acute exacerbations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Acute exacerbations of IPF (AE-IPF) are defined as an unexplained worsening or development of dyspnea within 30 days with new radiological infiltrates at HRCT abnormality often superimposed on a background consistent with UIP pattern. The yearly incidence of AE-IPF is between 10 and 15% of all patients. The prognosis of AE-IPF is poor, with mortality ranging from 78% to 96%.<sup id="cite_ref-AgarwalJindal_56-0" class="reference"><a href="#cite_note-AgarwalJindal-56"><span>[</span>56<span>]</span></a></sup> Other causes of AE-IPF such as pulmonary embolism, congestive heart failure, pneumothorax, or infection need to be excluded. Pulmonary infection have to be ruled out by endotracheal aspirate or BAL.</p>
<p>Many patients experiencing acute deterioration require intensive care treatment, particularly when respiratory failure is associated with hemodynamic instability, significant co-morbidities or severe hypoxemia.<sup id="cite_ref-SternMal_57-0" class="reference"><a href="#cite_note-SternMal-57"><span>[</span>57<span>]</span></a></sup> However, mortality during hospitalization is high.<sup id="cite_ref-AgarwalJindal_56-1" class="reference"><a href="#cite_note-AgarwalJindal-56"><span>[</span>56<span>]</span></a></sup> Mechanical ventilation should be introduced only after carefully weighing the patient’s long-term prognosis and, whenever possible, the patient’s wishes. However, current guidelines discourage the use of mechanical ventilation in patients with respiratory failure secondary to IPF.<sup id="cite_ref-RaghuCollard_2-32" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=16" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Comparison_of_the_5-year_survival_rate_for_IPF.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Comparison_of_the_5-year_survival_rate_for_IPF.jpg/220px-Comparison_of_the_5-year_survival_rate_for_IPF.jpg" width="220" height="127" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Comparison_of_the_5-year_survival_rate_for_IPF.jpg/330px-Comparison_of_the_5-year_survival_rate_for_IPF.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Comparison_of_the_5-year_survival_rate_for_IPF.jpg/440px-Comparison_of_the_5-year_survival_rate_for_IPF.jpg 2x" data-file-width="720" data-file-height="416" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Comparison_of_the_5-year_survival_rate_for_IPF.jpg" class="internal" title="Enlarge"></a></div>
Comparison of the 5-year survival rate for IPF and common malignancies. Adapted from Bjoraker et al. 1998.<sup id="cite_ref-BjorakerRyu_58-0" class="reference"><a href="#cite_note-BjorakerRyu-58"><span>[</span>58<span>]</span></a></sup></div>
</div>
</div>
<p>The clinical course of IPF can be unpredictable.<sup id="cite_ref-RaghuCollard_2-33" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-BjorakerRyu_58-1" class="reference"><a href="#cite_note-BjorakerRyu-58"><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-KimCollard_59-0" class="reference"><a href="#cite_note-KimCollard-59"><span>[</span>59<span>]</span></a></sup> IPF progression is associated with an estimated median survival time of 2 to 5 years following diagnosis.<sup id="cite_ref-NIH_IPF_1-2" class="reference"><a href="#cite_note-NIH_IPF-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-RaghuCollard_2-34" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup> The 5-year survival for IPF ranges between 20–40%,<sup id="cite_ref-KimCollard_59-1" class="reference"><a href="#cite_note-KimCollard-59"><span>[</span>59<span>]</span></a></sup> a mortality rate higher than that of a number of malignancies, including colon cancer, multiple myeloma and bladder cancer.<sup id="cite_ref-BjorakerRyu_58-2" class="reference"><a href="#cite_note-BjorakerRyu-58"><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-KimCollard_59-2" class="reference"><a href="#cite_note-KimCollard-59"><span>[</span>59<span>]</span></a></sup></p>
<p>Recently a multidimensional index and staging system has been proposed to predict mortality in IPF.<sup id="cite_ref-LeyRyerson_60-0" class="reference"><a href="#cite_note-LeyRyerson-60"><span>[</span>60<span>]</span></a></sup> The name of the index is GAP and is based on gender [G], age [A], and two lung physiology variables [P] (FVC and DL<small>CO</small>] that are commonly measured in clinical practice to predict mortality in IPF. The highest stage of GAP (stage III) has been found to be associated with a 39% risk of mortality at 1 year.<sup id="cite_ref-LeyRyerson_60-1" class="reference"><a href="#cite_note-LeyRyerson-60"><span>[</span>60<span>]</span></a></sup> This model has also been evaluated in IPF and other ILDs and shown good performance in predicting mortality in all main ILD subtypes. A modified ILD-GAP Index has been developed for application across ILD subtypes to provide disease-specific survival estimates.<sup id="cite_ref-RyersonVittinghoff_61-0" class="reference"><a href="#cite_note-RyersonVittinghoff-61"><span>[</span>61<span>]</span></a></sup> In IPF patients, the overall mortality at 5 years rate is high but the annual rate of all-cause mortality in patients with mild to moderate lung impairment is relatively low. This is the reason why change in lung function (FVC) is usually measured in 1-year clinical trials of IPF treatments rather than survival.<sup id="cite_ref-KingAlbera_62-0" class="reference"><a href="#cite_note-KingAlbera-62"><span>[</span>62<span>]</span></a></sup></p>
<p>In addition to clinical and physiological parameters to predict how rapidly patients with IPF might progress, genetic and molecular features are also associated with IPF mortality. For example, it has been shown that IPF patients who have a specific genotype in the mucin MUC5B gene polymorphism (see above) experience slower decline in FVC and significantly improved survival.<sup id="cite_ref-PeljtoZhang_63-0" class="reference"><a href="#cite_note-PeljtoZhang-63"><span>[</span>63<span>]</span></a></sup><sup id="cite_ref-StockSato_64-0" class="reference"><a href="#cite_note-StockSato-64"><span>[</span>64<span>]</span></a></sup> Even if such data are interesting from a scientific point of view, the application in the clinical routine of a prognostic model based on specific genotypes is still not possible.</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=17" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Although rare, IPF is the most common form of IIP.<sup id="cite_ref-ATS.2FERS_3-13" class="reference"><a href="#cite_note-ATS.2FERS-3"><span>[</span>3<span>]</span></a></sup> The prevalence of IPF has been estimated between 14.0 and 42.7 per 100,000 persons based on a USA analysis of healthcare claims data, with variation depending on the case definitions used in this analyses.<sup id="cite_ref-PulmonaryFibrosis_5-3" class="reference"><a href="#cite_note-PulmonaryFibrosis-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-RaghuWeycker_7-1" class="reference"><a href="#cite_note-RaghuWeycker-7"><span>[</span>7<span>]</span></a></sup> IPF is more common in men than in women and is usually diagnosed in people over 50 years of age.<sup id="cite_ref-RaghuCollard_2-35" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup></p>
<p>The <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of IPF is difficult to determine as uniform diagnostic criteria have not been applied consistently.<sup id="cite_ref-RaghuCollard_2-36" class="reference"><a href="#cite_note-RaghuCollard-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-RaghuWeycker_7-2" class="reference"><a href="#cite_note-RaghuWeycker-7"><span>[</span>7<span>]</span></a></sup> A recent study from the USA estimated the incidence of IPF to be between 6.8 and 16.3 per 100,000 persons. In the 27 European Union countries, a range of sources estimate an incidence of 4.6–7.4 people per 100,000 of the population,<sup id="cite_ref-GribbinHubbard_65-0" class="reference"><a href="#cite_note-GribbinHubbard-65"><span>[</span>65<span>]</span></a></sup><sup id="cite_ref-NavaratnamFleming_66-0" class="reference"><a href="#cite_note-NavaratnamFleming-66"><span>[</span>66<span>]</span></a></sup> suggesting that approximately 30,000–35,000 new patients will be diagnosed with IPF each year.<sup id="cite_ref-PulmonaryFibrosis_5-4" class="reference"><a href="#cite_note-PulmonaryFibrosis-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-EurostatNewsJuly2010_67-0" class="reference"><a href="#cite_note-EurostatNewsJuly2010-67"><span>[</span>67<span>]</span></a></sup></p>
<p>A recent single-centre, retrospective, observational cohort study including incident patients diagnosed with ILD at Aarhus University Hospital (Denmark) between 2003 and 2009 revealed an incidence of 4.1 per 100,000 inhabitants/year for ILD. IPF was the most common diagnosis (28%) followed by connective tissue disease-related ILD (14%), hypersensitivity pneumonitis (7%) and non-specific interstitial pneumonia (NSIP) (7%). IPF incidence was 1.3 per 100,000 inhabitants/year.<sup id="cite_ref-HyldgaardHilberg_68-0" class="reference"><a href="#cite_note-HyldgaardHilberg-68"><span>[</span>68<span>]</span></a></sup></p>
<p>Due to a heterogeneous distribution of the disease across European countries, epidemiological data needs to be updated through a Europe-wide registry for ILD and IPF.</p>
<h2><span class="mw-headline" id="In_other_species">In other species</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=18" title="Edit section: In other species">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>IPF has been recognized in several breeds of both dogs and cats,<sup id="cite_ref-WilliamsMalarkey_69-0" class="reference"><a href="#cite_note-WilliamsMalarkey-69"><span>[</span>69<span>]</span></a></sup> and has been best characterized in <a href="/wiki/West_Highland_White_Terriers" title="West Highland White Terriers" class="mw-redirect">West Highland White Terriers</a>.<sup id="cite_ref-Webb_70-0" class="reference"><a href="#cite_note-Webb-70"><span>[</span>70<span>]</span></a></sup> Veterinary patients with the condition share many of the same clinical signs as their human counterparts, including progressive exercise intolerance, increased respiratory rate, and eventual respiratory distress.<sup id="cite_ref-Canine_71-0" class="reference"><a href="#cite_note-Canine-71"><span>[</span>71<span>]</span></a></sup> Prognosis is generally poor.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=19" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist" style="list-style-type: decimal;">
<ol class="references">
<li id="cite_note-NIH_IPF-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-NIH_IPF_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIH_IPF_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NIH_IPF_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nhlbi.nih.gov/health/health-topics/topics/ipf/">"Idiopathic Pulmonary Fibrosis"</a>. <i><a rel="nofollow" class="external free" href="http://www.nhlbi.nih.gov/">http://www.nhlbi.nih.gov/</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">5 August</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+Pulmonary+Fibrosis&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nhlbi.nih.gov%2Fhealth%2Fhealth-topics%2Ftopics%2Fipf%2F&amp;rft.jtitle=http%3A%2F%2Fwww.nhlbi.nih.gov%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RaghuCollard-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-RaghuCollard_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-29"><sup><i><b>ad</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-30"><sup><i><b>ae</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-31"><sup><i><b>af</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-32"><sup><i><b>ag</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-33"><sup><i><b>ah</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-34"><sup><i><b>ai</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-35"><sup><i><b>aj</b></i></sup></a> <a href="#cite_ref-RaghuCollard_2-36"><sup><i><b>ak</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Raghu G, Collard HR, Egan JJ et al. (2011). "An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management". <i>Am. J Respir. Crit. Care Med.</i> <b>183</b> (6): 788–824. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.2009-040GL">10.1164/rccm.2009-040GL</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21471066">21471066</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=An+official+ATS%2FERS%2FJRS%2FALAT+statement%3A+Idiopathic+pulmonary+fibrosis%3A+Evidence-based+guidelines+for+diagnosis+and+management&amp;rft.aulast=Raghu+G%2C+Collard+HR%2C+Egan+JJ&amp;rft.au=Raghu+G%2C+Collard+HR%2C+Egan+JJ&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.2009-040GL&amp;rft_id=info%3Apmid%2F21471066&amp;rft.issue=6&amp;rft.jtitle=Am.+J+Respir.+Crit.+Care+Med.&amp;rft.pages=788-824&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=183" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-ATS.2FERS-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-ATS.2FERS_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-ATS.2FERS_3-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text">American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This official statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was approved by the ATS board of directors, June 2013 and by the ERS Steering Committee, March 2013. <i>Am Respir Crit Care Med.</i> 188 (6): 733-748. September 15, 2013. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/24032382?dopt=Abstract">PMID 24032382</a></span></li>
<li id="cite_note-MeltzerNoble-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-MeltzerNoble_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MeltzerNoble_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Meltzer EB, Noble PW (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2330030">"Idiopathic pulmonary fibrosis"</a>. <i>Orphanet J Rare Dis.</i> <b>3</b> (1). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1750-1172-3-8">10.1186/1750-1172-3-8</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2330030">2330030</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18366757">18366757</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+pulmonary+fibrosis&amp;rft.aulast=Meltzer+EB%2C+Noble+PW&amp;rft.au=Meltzer+EB%2C+Noble+PW&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2330030&amp;rft_id=info%3Adoi%2F10.1186%2F1750-1172-3-8&amp;rft_id=info%3Apmc%2F2330030&amp;rft_id=info%3Apmid%2F18366757&amp;rft.issue=1&amp;rft.jtitle=Orphanet+J+Rare+Dis.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PulmonaryFibrosis-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-PulmonaryFibrosis_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PulmonaryFibrosis_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PulmonaryFibrosis_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-PulmonaryFibrosis_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-PulmonaryFibrosis_5-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text">Pulmonary Fibrosis Foundation. "Prevalence and Incidence". Pulmonaryfibrosis.org. Retrieved 2013-04-11</span></li>
<li id="cite_note-FlahertyMumford-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-FlahertyMumford_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FlahertyMumford_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, Travis WD, Flint A et al. (2007). "Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia". <i>Am J Respir Crit Care Med.</i> <b>168</b> (5): 543–548. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200209-1112OC">10.1164/rccm.200209-1112OC</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12773329">12773329</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Prognostic+implications+of+physiologic+and+radiographic+changes+in+idiopathic+interstitial+pneumonia&amp;rft.au=Flaherty+KR%2C+Mumford+JA%2C+Murray+S%2C+Kazerooni+EA%2C+Gross+BH%2C+Colby+TV%2C+Travis+WD%2C+Flint+A&amp;rft.aulast=Flaherty+KR%2C+Mumford+JA%2C+Murray+S%2C+Kazerooni+EA%2C+Gross+BH%2C+Colby+TV%2C+Travis+WD%2C+Flint+A&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200209-1112OC&amp;rft_id=info%3Apmid%2F12773329&amp;rft.issue=5&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med.&amp;rft.pages=543-548&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=168" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-RaghuWeycker-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-RaghuWeycker_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RaghuWeycker_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RaghuWeycker_7-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Raghu G, Weycker D, Edesberg J, Bradford WZ, Oster G (2006). "Incidence and prevalence of idiopathic pulmonary fibrosis". <i>Am. J Respir. Crit. Care Med</i> <b>174</b> (7): 810–816. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200602-163oc">10.1164/rccm.200602-163oc</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Incidence+and+prevalence+of+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Raghu+G%2C+Weycker+D%2C+Edesberg+J%2C+Bradford+WZ%2C+Oster+G&amp;rft.au=Raghu+G%2C+Weycker+D%2C+Edesberg+J%2C+Bradford+WZ%2C+Oster+G&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200602-163oc&amp;rft.issue=7&amp;rft.jtitle=Am.+J+Respir.+Crit.+Care+Med&amp;rft.pages=810-816&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=174" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CottinCordier-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-CottinCordier_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CottinCordier_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Cottin V, Cordier JF (2012). "Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis". <i>Eur Respir J.</i> <b>40</b> (3): 519–521. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1183%2F09031936.00001612">10.1183/09031936.00001612</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22941541">22941541</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Velcro+crackles%3A+the+key+for+early+diagnosis+of+idiopathic+pulmonary+fibrosis&amp;rft.au=Cottin+V%2C+Cordier+JF&amp;rft.aulast=Cottin+V%2C+Cordier+JF&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1183%2F09031936.00001612&amp;rft_id=info%3Apmid%2F22941541&amp;rft.issue=3&amp;rft.jtitle=Eur+Respir+J.&amp;rft.pages=519-521&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BaughnmanShipley-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-BaughnmanShipley_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Baughman RP, Shipley RT, Loudon RG, Lower EE (1991). "Crackles in interstitial lung disease. Comparison of sarcoidosis and fibrosing alveolitis". <i>Chest</i> <b>100</b> (1): 96–101. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.100.1.96">10.1378/chest.100.1.96</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2060395">2060395</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Crackles+in+interstitial+lung+disease.+Comparison+of+sarcoidosis+and+fibrosing+alveolitis&amp;rft.au=Baughman+RP%2C+Shipley+RT%2C+Loudon+RG%2C+Lower+EE&amp;rft.aulast=Baughman+RP%2C+Shipley+RT%2C+Loudon+RG%2C+Lower+EE&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.100.1.96&amp;rft_id=info%3Apmid%2F2060395&amp;rft.issue=1&amp;rft.jtitle=Chest&amp;rft.pages=96-101&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-OlsonSwigris-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-OlsonSwigris_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OlsonSwigris_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-OlsonSwigris_10-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Olson AL, Swigris JJ (Mar 2012). "Idiopathic pulmonary fibrosis: diagnosis and epidemiology". <i>Clinics in chest medicine</i> <b>33</b> (1): 41–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ccm.2011.12.001">10.1016/j.ccm.2011.12.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22365244">22365244</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+pulmonary+fibrosis%3A+diagnosis+and+epidemiology&amp;rft.aulast=Olson+AL%2C+Swigris+JJ&amp;rft.au=Olson+AL%2C+Swigris+JJ&amp;rft.date=Mar+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccm.2011.12.001&amp;rft_id=info%3Apmid%2F22365244&amp;rft.issue=1&amp;rft.jtitle=Clinics+in+chest+medicine&amp;rft.pages=41-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Williams-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Williams_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Williams, KJ (March 2014). "Gammaherpesviruses and Pulmonary Fibrosis: Evidence From Humans, Horses, and Rodents". <i>Veterinary Pathology</i> <b>51</b> (2): 372–384. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1177%2F0300985814521838">10.1177/0300985814521838</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24569614">24569614</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Gammaherpesviruses+and+Pulmonary+Fibrosis%3A+Evidence+From+Humans%2C+Horses%2C+and+Rodents&amp;rft.aulast=Williams%2C+KJ&amp;rft.au=Williams%2C+KJ&amp;rft.date=March+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F0300985814521838&amp;rft_id=info%3Apmid%2F24569614&amp;rft.issue=2&amp;rft.jtitle=Veterinary+Pathology&amp;rft.pages=372-384&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-GarciaBuendia-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-GarciaBuendia_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">García-Sancho C, Buendía-Roldán I, Fernández-Plata MR, Navarro C, Pérez-Padilla R, Vargas MH, Loyd JE, Selman M. Buendía-Roldán I, Fernández-Plata MR et al. (2011). "Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis". <i>Respir Med.</i> <b>105</b> (12): 1902–1990. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.rmed.2011.08.022">10.1016/j.rmed.2011.08.022</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21917441">21917441</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Familial+pulmonary+fibrosis+is+the+strongest+risk+factor+for+idiopathic+pulmonary+fibrosis&amp;rft.au=Garc%C3%ADa-Sancho+C%2C+Buend%C3%ADa-Rold%C3%A1n+I%2C+Fern%C3%A1ndez-Plata+MR%2C+Navarro+C%2C+P%C3%A9rez-Padilla+R%2C+Vargas+MH%2C+Loyd+JE%2C+Selman+M.+Buend%C3%ADa-Rold%C3%A1n+I%2C+Fern%C3%A1ndez-Plata+MR&amp;rft.aulast=Garc%C3%ADa-Sancho+C%2C+Buend%C3%ADa-Rold%C3%A1n+I%2C+Fern%C3%A1ndez-Plata+MR%2C+Navarro+C%2C+P%C3%A9rez-Padilla+R%2C+Vargas+MH%2C+Loyd+JE%2C+Selman+M.+Buend%C3%ADa-Rold%C3%A1n+I%2C+Fern%C3%A1ndez-Plata+MR&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rmed.2011.08.022&amp;rft_id=info%3Apmid%2F21917441&amp;rft.issue=12&amp;rft.jtitle=Respir+Med.&amp;rft.pages=1902-1990&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=105" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-HarariCaminati-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-HarariCaminati_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-HarariCaminati_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Harari S, Caminati A (2010). "IPF: new insight on pathogenesis and treatment". <i>Allergy</i> <b>65</b> (5): 537–553. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1398-9995.2009.02305">10.1111/j.1398-9995.2009.02305</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20121758">20121758</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=IPF%3A+new+insight+on+pathogenesis+and+treatment&amp;rft.au=Harari+S%2C+Caminati+A&amp;rft.aulast=Harari+S%2C+Caminati+A&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1398-9995.2009.02305&amp;rft_id=info%3Apmid%2F20121758&amp;rft.issue=5&amp;rft.jtitle=Allergy&amp;rft.pages=537-553&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-LoomisFlaherty-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-LoomisFlaherty_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-LoomisFlaherty_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Loomis-King H, Flaherty KR, Moore BB (April 2013). "Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis". <i>Current Opinion in Pharmacology</i> <b>13</b> (3): 377–385. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.coph.2013.03.015">10.1016/j.coph.2013.03.015</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Pathogenesis%2C+current+treatments+and+future+directions+for+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Loomis-King+H%2C+Flaherty+KR%2C+Moore+BB&amp;rft.au=Loomis-King+H%2C+Flaherty+KR%2C+Moore+BB&amp;rft.date=April+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.coph.2013.03.015&amp;rft.issue=3&amp;rft.jtitle=Current+Opinion+in+Pharmacology&amp;rft.pages=377-385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PardoSelman-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-PardoSelman_15-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pardo A, Selman M (2002). "Idiopathic pulmonary fibrosis: new insights in its pathogenesis". <i>Int J Biochem Cell Biol.</i> <b>34</b> (12): 1534–1538. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fs1357-2725%2802%2900091-2">10.1016/s1357-2725(02)00091-2</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+pulmonary+fibrosis%3A+new+insights+in+its+pathogenesis&amp;rft.aulast=Pardo+A%2C+Selman+M&amp;rft.au=Pardo+A%2C+Selman+M&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fs1357-2725%2802%2900091-2&amp;rft.issue=12&amp;rft.jtitle=Int+J+Biochem+Cell+Biol.&amp;rft.pages=1534-1538&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SelmanKing-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-SelmanKing_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Selman M, King TE, Pardo A (2001). "Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy". <i>Annals of Internal Medicine</i> <b>134</b> (2): 136–151. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-134-2-200101160-00015">10.7326/0003-4819-134-2-200101160-00015</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11177318">11177318</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+pulmonary+fibrosis%3A+prevailing+and+evolving+hypotheses+about+its+pathogenesis+and+implications+for+therapy&amp;rft.aulast=Selman+M%2C+King+TE%2C+Pardo+A&amp;rft.au=Selman+M%2C+King+TE%2C+Pardo+A&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-134-2-200101160-00015&amp;rft_id=info%3Apmid%2F11177318&amp;rft.issue=2&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.pages=136-151&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=134" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-OMIM-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-OMIM_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OMIM_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://omim.org/entry/178500">Online 'Mendelian Inheritance in Man' (OMIM) 178500</a></span></li>
<li id="cite_note-Mathai-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mathai_18-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mathai S et al. (2014). "Genetic susceptibility and pulmonary fibrosis". <i>Curr Opin Pulm Med</i> <b>20</b> (5): 429–435. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FMCP.0000000000000074">10.1097/MCP.0000000000000074</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25022318">25022318</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Genetic+susceptibility+and+pulmonary+fibrosis&amp;rft.aulast=Mathai+S&amp;rft.au=Mathai+S&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FMCP.0000000000000074&amp;rft_id=info%3Apmid%2F25022318&amp;rft.issue=5&amp;rft.jtitle=Curr+Opin+Pulm+Med&amp;rft.pages=429-435&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-KropskiMitchell-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-KropskiMitchell_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kropski JA, Mitchell DB, Markin C et al. (Feb 6, 2014). "A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia". <i>Chest</i> <b>146</b> (1): e1–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.13-2224">10.1378/chest.13-2224</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24504062">24504062</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=A+novel+dyskerin+%28DKC1%29+mutation+is+associated+with+familial+interstitial+pneumonia&amp;rft.au=Kropski+JA%2C+Mitchell+DB%2C+Markin+C&amp;rft.aulast=Kropski+JA%2C+Mitchell+DB%2C+Markin+C&amp;rft.date=Feb+6%2C+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.13-2224&amp;rft_id=info%3Apmid%2F24504062&amp;rft.issue=1&amp;rft.jtitle=Chest&amp;rft.pages=e1-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-FlahertyKing-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-FlahertyKing_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA et al. (2004). "Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?". <i>Am J Respir Crit Care Med.</i> <b>170</b> (8): 904–910. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200402-147OC">10.1164/rccm.200402-147OC</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15256390">15256390</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+interstitial+pneumonia%3A+what+is+the+effect+of+a+multidisciplinary+approach+to+diagnosis%3F&amp;rft.au=Flaherty+KR%2C+King+TE%2C+Raghu+G%2C+Lynch+JP%2C+Colby+TV%2C+Travis+WD%2C+Gross+BH%2C+Kazerooni+EA&amp;rft.aulast=Flaherty+KR%2C+King+TE%2C+Raghu+G%2C+Lynch+JP%2C+Colby+TV%2C+Travis+WD%2C+Gross+BH%2C+Kazerooni+EA&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200402-147OC&amp;rft_id=info%3Apmid%2F15256390&amp;rft.issue=8&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med.&amp;rft.pages=904-910&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=170" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-FlahertyAndrei-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-FlahertyAndrei_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Flaherty KR, Andrei AC, King TE Jr, Raghu G, Colby TV, Wells A, Bassily N, Brown K et al. (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1899268">"Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?"</a>. <i>Am J Respir Crit Care Med.</i> <b>175</b> (10): 1054–1060. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200606-833OC">10.1164/rccm.200606-833OC</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1899268">1899268</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17255566">17255566</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+interstitial+pneumonia%3A+do+community+and+academic+physicians+agree+on+diagnosis%3F&amp;rft.au=Flaherty+KR%2C+Andrei+AC%2C+King+TE+Jr%2C+Raghu+G%2C+Colby+TV%2C+Wells+A%2C+Bassily+N%2C+Brown+K&amp;rft.aulast=Flaherty+KR%2C+Andrei+AC%2C+King+TE+Jr%2C+Raghu+G%2C+Colby+TV%2C+Wells+A%2C+Bassily+N%2C+Brown+K&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1899268&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200606-833OC&amp;rft_id=info%3Apmc%2F1899268&amp;rft_id=info%3Apmid%2F17255566&amp;rft.issue=10&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med.&amp;rft.pages=1054-1060&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=175" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-OhshimoBonella-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-OhshimoBonella_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009). "Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis". <i>Am J Respir Crit Care Med.</i> <b>179</b> (11): 1043–1047. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200808-1313oc">10.1164/rccm.200808-1313oc</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Significance+of+bronchoalveolar+lavage+for+the+diagnosis+of+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Ohshimo+S%2C+Bonella+F%2C+Cui+A%2C+Beume+M%2C+Kohno+N%2C+Guzman+J%2C+Costabel+U&amp;rft.au=Ohshimo+S%2C+Bonella+F%2C+Cui+A%2C+Beume+M%2C+Kohno+N%2C+Guzman+J%2C+Costabel+U&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200808-1313oc&amp;rft.issue=11&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med.&amp;rft.pages=1043-1047&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=179" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PellegrinoViegi-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-PellegrinoViegi_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP et al. (2005). "Interpretative strategies for lung function tests". <i>Eur Respir J.</i> <b>26</b> (5): 948–968. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1183%2F09031936.05.00035205">10.1183/09031936.05.00035205</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16264058">16264058</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Interpretative+strategies+for+lung+function+tests&amp;rft.aulast=Pellegrino+R%2C+Viegi+G%2C+Brusasco+V%2C+Crapo+RO%2C+Burgos+F%2C+Casaburi+R%2C+Coates+A%2C+van+der+Grinten+CP&amp;rft.au=Pellegrino+R%2C+Viegi+G%2C+Brusasco+V%2C+Crapo+RO%2C+Burgos+F%2C+Casaburi+R%2C+Coates+A%2C+van+der+Grinten+CP&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1183%2F09031936.05.00035205&amp;rft_id=info%3Apmid%2F16264058&amp;rft.issue=5&amp;rft.jtitle=Eur+Respir+J.&amp;rft.pages=948-968&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-NobleAlbera-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-NobleAlbera_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NobleAlbera_24-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NobleAlbera_24-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L et al. (2011). "Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials". <i>Lancet</i> <b>377</b> (9779): 1760–1769. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2811%2960405-4">10.1016/S0140-6736(11)60405-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21571362">21571362</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Pirfenidone+in+patients+with+idiopathic+pulmonary+fibrosis+%28CAPACITY%29%3A+two+randomised+trials&amp;rft.aulast=Noble+PW%2C+Albera+C%2C+Bradford+WZ%2C+Costabel+U%2C+Glassberg+MK%2C+Kardatzke+D%2C+King+TE%2C+Lancaster+L&amp;rft.au=Noble+PW%2C+Albera+C%2C+Bradford+WZ%2C+Costabel+U%2C+Glassberg+MK%2C+Kardatzke+D%2C+King+TE%2C+Lancaster+L&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2811%2960405-4&amp;rft_id=info%3Apmid%2F21571362&amp;rft.issue=9779&amp;rft.jtitle=Lancet&amp;rft.pages=1760-1769&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=377" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-MartinezSafrin-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-MartinezSafrin_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, et al. IPF study group (2005). "The clinical course of patients with idiopathic pulmonary fibrosis". <i>Annals of Internal Medicine</i> <b>377</b> (9779): 1760–1769. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2811%2960405-4">10.1016/S0140-6736(11)60405-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21571362">21571362</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=The+clinical+course+of+patients+with+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Martinez+FJ%2C+Safrin+S%2C+Weycker+D%2C+Starko+KM%2C+Bradford+WZ%2C+King+TE+Jr%2C+Flaherty+KR%2C+Schwartz+DA%2C+et+al.+IPF+study+group&amp;rft.au=Martinez+FJ%2C+Safrin+S%2C+Weycker+D%2C+Starko+KM%2C+Bradford+WZ%2C+King+TE+Jr%2C+Flaherty+KR%2C+Schwartz+DA%2C+et+al.+IPF+study+group&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2811%2960405-4&amp;rft_id=info%3Apmid%2F21571362&amp;rft.issue=9779&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.pages=1760-1769&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=377" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-KingBradford-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-KingBradford_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-KingBradford_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-KingBradford_26-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, et al. IPF study group (2014). "A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis". <i>N Engl J Med</i> <b>370</b> (22): 2083–2092. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1402582">10.1056/NEJMoa1402582</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24836312">24836312</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=A+phase+3+trial+of+pirfenidone+in+patients+with+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Martinez+FJ%2C+Safrin+S%2C+Weycker+D%2C+Starko+KM%2C+Bradford+WZ%2C+King+TE+Jr%2C+Flaherty+KR%2C+Schwartz+DA%2C+et+al.+IPF+study+group&amp;rft.au=Martinez+FJ%2C+Safrin+S%2C+Weycker+D%2C+Starko+KM%2C+Bradford+WZ%2C+King+TE+Jr%2C+Flaherty+KR%2C+Schwartz+DA%2C+et+al.+IPF+study+group&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1402582&amp;rft_id=info%3Apmid%2F24836312&amp;rft.issue=22&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=2083-2092&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=370" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RicheldiduBois-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-RicheldiduBois_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RicheldiduBois_27-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RicheldiduBois_27-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, M Costabel U, Cottin V, Flaherty KR, for the INPULSIS Trial Investigators. (2014). "Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis". <i>N Engl J Med</i> <b>370</b> (22): 2071–2082. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2Fnejmoa1402584">10.1056/nejmoa1402584</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24836310">24836310</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Efficacy+and+safety+of+nintedanib+in+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Richeldi+L%2C+du+Bois+RM%2C+Raghu+G%2C+Azuma+A%2C+Brown+KK%2C+M+Costabel+U%2C+Cottin+V%2C+Flaherty+KR%2C+for+the+INPULSIS+Trial+Investigators.&amp;rft.au=Richeldi+L%2C+du+Bois+RM%2C+Raghu+G%2C+Azuma+A%2C+Brown+KK%2C+M+Costabel+U%2C+Cottin+V%2C+Flaherty+KR%2C+for+the+INPULSIS+Trial+Investigators.&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmoa1402584&amp;rft_id=info%3Apmid%2F24836310&amp;rft.issue=22&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=2071-2082&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=370" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-LeeMcLaughlin-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-LeeMcLaughlin_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee JS, McLaughlin S, Collard HR (2011). "Comprehensive care of the patient with idiopathic pulmonary fibrosis". <i>Current Opinion in Pulmonary Medicine</i> <b>17</b> (5): 348–354. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2Fmcp.0b013e328349721b">10.1097/mcp.0b013e328349721b</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Comprehensive+care+of+the+patient+with+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Lee+JS%2C+McLaughlin+S%2C+Collard+HR&amp;rft.au=Lee+JS%2C+McLaughlin+S%2C+Collard+HR&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2Fmcp.0b013e328349721b&amp;rft.issue=5&amp;rft.jtitle=Current+Opinion+in+Pulmonary+Medicine&amp;rft.pages=348-354&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-KingAlberaBradford-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-KingAlberaBradford_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA et al. (2009). "Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis". <i>Lancet</i> <b>374</b> (9685): 222–228. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2809%2960551-1">10.1016/S0140-6736(09)60551-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19570573">19570573</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Effect+of+interferon+gamma-1b+on+survival+in+patients+with+idiopathic+pulmonary+fibrosis&amp;rft.au=King+TE+Jr%2C+Albera+C%2C+Bradford+WZ%2C+Costabel+U%2C+Hormel+P%2C+Lancaster+L%2C+Noble+PW%2C+Sahn+SA&amp;rft.aulast=King+TE+Jr%2C+Albera+C%2C+Bradford+WZ%2C+Costabel+U%2C+Hormel+P%2C+Lancaster+L%2C+Noble+PW%2C+Sahn+SA&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2809%2960551-1&amp;rft_id=info%3Apmid%2F19570573&amp;rft.issue=9685&amp;rft.jtitle=Lancet&amp;rft.pages=222-228&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=374" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-KingBrown-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-KingBrown_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">King TE Jr, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I et al. (2011). "BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis". <i>Am J Respir Crit Care Med</i> <b>184</b> (1): 92–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.201011-1874OC">10.1164/rccm.201011-1874OC</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21474646">21474646</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=BUILD-3%3A+a+randomized%2C+controlled+trial+of+bosentan+in+idiopathic+pulmonary+fibrosis&amp;rft.au=King+TE+Jr%2C+Brown+KK%2C+Raghu+G%2C+du+Bois+RM%2C+Lynch+DA%2C+Martinez+F%2C+Valeyre+D%2C+Leconte+I&amp;rft.aulast=King+TE+Jr%2C+Brown+KK%2C+Raghu+G%2C+du+Bois+RM%2C+Lynch+DA%2C+Martinez+F%2C+Valeyre+D%2C+Leconte+I&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.201011-1874OC&amp;rft_id=info%3Apmid%2F21474646&amp;rft.issue=1&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med&amp;rft.pages=92-99&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=184" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-RaghuBehr-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-RaghuBehr_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD et al. (2013). "Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial". <i>Ann Intern Med</i> <b>158</b> (9): 641–649. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-158-9-201305070-00003">10.7326/0003-4819-158-9-201305070-00003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23648946">23648946</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Treatment+of+idiopathic+pulmonary+fibrosis+with+ambrisentan%3A+a+parallel%2C+randomized+trial&amp;rft.aulast=Raghu+G%2C+Behr+J%2C+Brown+KK%2C+Egan+JJ%2C+Kawut+SM%2C+Flaherty+KR%2C+Martinez+FJ%2C+Nathan+SD&amp;rft.au=Raghu+G%2C+Behr+J%2C+Brown+KK%2C+Egan+JJ%2C+Kawut+SM%2C+Flaherty+KR%2C+Martinez+FJ%2C+Nathan+SD&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-158-9-201305070-00003&amp;rft_id=info%3Apmid%2F23648946&amp;rft.issue=9&amp;rft.jtitle=Ann+Intern+Med&amp;rft.pages=641-649&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=158" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-NothAnstrom-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-NothAnstrom_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA (2012). "Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet) A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis". <i>Am J Respir Crit Care Med</i> <b>186</b> (1): 88–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.201202-0314OC">10.1164/rccm.201202-0314OC</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22561965">22561965</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+Pulmonary+Fibrosis+Clinical+Research+Network+%28IPFnet%29+A+placebo-controlled+randomized+trial+of+warfarin+in+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Noth+I%2C+Anstrom+KJ%2C+Calvert+SB%2C+de+Andrade+J%2C+Flaherty+KR%2C+Glazer+C%2C+Kaner+RJ%2C+Olman+MA&amp;rft.au=Noth+I%2C+Anstrom+KJ%2C+Calvert+SB%2C+de+Andrade+J%2C+Flaherty+KR%2C+Glazer+C%2C+Kaner+RJ%2C+Olman+MA&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.201202-0314OC&amp;rft_id=info%3Apmid%2F22561965&amp;rft.issue=1&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med&amp;rft.pages=88-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=186" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SchaeferRuhrmund-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-SchaeferRuhrmund_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K (2011). "Antifibrotic activities of pirfenidone in animal models". <i>Eur Respir Rev</i> <b>20</b> (120): 85–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1183%2F09059180.00001111">10.1183/09059180.00001111</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21632796">21632796</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Antifibrotic+activities+of+pirfenidone+in+animal+models&amp;rft.aulast=Schaefer+CJ%2C+Ruhrmund+DW%2C+Pan+L%2C+Seiwert+SD%2C+Kossen+K&amp;rft.au=Schaefer+CJ%2C+Ruhrmund+DW%2C+Pan+L%2C+Seiwert+SD%2C+Kossen+K&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1183%2F09059180.00001111&amp;rft_id=info%3Apmid%2F21632796&amp;rft.issue=120&amp;rft.jtitle=Eur+Respir+Rev&amp;rft.pages=85-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418991.htm">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418991.htm</a></span></li>
<li id="cite_note-TaniguchiEbina-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-TaniguchiEbina_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H et al. (2010). "Pirfenidone in idiopathic pulmonary fibrosis". <i>Eur Respir J</i> <b>35</b> (4): 821–829. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1183%2F09031936.00005209">10.1183/09031936.00005209</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19996196">19996196</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Pirfenidone+in+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Taniguchi+H%2C+Ebina+M%2C+Kondoh+Y%2C+Ogura+T%2C+Azuma+A%2C+Suga+M%2C+Taguchi+Y%2C+Takahashi+H&amp;rft.au=Taniguchi+H%2C+Ebina+M%2C+Kondoh+Y%2C+Ogura+T%2C+Azuma+A%2C+Suga+M%2C+Taguchi+Y%2C+Takahashi+H&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1183%2F09031936.00005209&amp;rft_id=info%3Apmid%2F19996196&amp;rft.issue=4&amp;rft.jtitle=Eur+Respir+J&amp;rft.pages=821-829&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=35" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-SpagnoloDelGiovane-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-SpagnoloDelGiovane_36-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Spagnolo P, Del Giovane C, Luppi F, Cerri S, Balduzzi S, Walters EH, D'Amico R, Richeldi L (2010). "Non-steroid agents for idiopathic pulmonary fibrosis". <i>Cochrane Database Syst Rev</i> (9): CD003134. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD003134.pub2">10.1002/14651858.CD003134.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20824834">20824834</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Non-steroid+agents+for+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Spagnolo+P%2C+Del+Giovane+C%2C+Luppi+F%2C+Cerri+S%2C+Balduzzi+S%2C+Walters+EH%2C+D%27Amico+R%2C+Richeldi+L&amp;rft.au=Spagnolo+P%2C+Del+Giovane+C%2C+Luppi+F%2C+Cerri+S%2C+Balduzzi+S%2C+Walters+EH%2C+D%27Amico+R%2C+Richeldi+L&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003134.pub2&amp;rft_id=info%3Apmid%2F20824834&amp;rft.issue=9&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD003134&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-IntermunePress-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-IntermunePress_37-0">^</a></b></span> <span class="reference-text">[InterMune Receives FDA Breakthrough Therapy Designation for Pirfenidone, an Investigational Treatment for IPF. Press release. Retrieved 2014-04-08: <a rel="nofollow" class="external free" href="http://investor.intermune.com/phoenix.zhtml?c=100067&amp;p=irol-newsArticle&amp;ID=1948523&amp;highlight=">http://investor.intermune.com/phoenix.zhtml?c=100067&amp;p=irol-newsArticle&amp;ID=1948523&amp;highlight=</a>]</span></li>
<li id="cite_note-IntermuneAnnounces-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-IntermuneAnnounces_38-0">^</a></b></span> <span class="reference-text">[InterMune Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States. Press release. Retrieved 2014-04-08: <a rel="nofollow" class="external free" href="http://investor.intermune.com/phoenix.zhtml?c=100067&amp;p=irol-newsArticle&amp;ID=1931863&amp;highlight=">http://investor.intermune.com/phoenix.zhtml?c=100067&amp;p=irol-newsArticle&amp;ID=1931863&amp;highlight=</a>]</span></li>
<li id="cite_note-DemedtsBehr-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-DemedtsBehr_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M et al. (2005). "High-dose acetylcysteine in idiopathic pulmonary fibrosis". <i>N Engl J Med.</i> <b>353</b> (21): 2229–2242. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa042976">10.1056/NEJMoa042976</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16306520">16306520</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=High-dose+acetylcysteine+in+idiopathic+pulmonary+fibrosis&amp;rft.au=Demedts+M%2C+Behr+J%2C+Buhl+R%2C+Costabel+U%2C+Dekhuijzen+R%2C+Jansen+HM%2C+MacNee+W%2C+Thomeer+M&amp;rft.aulast=Demedts+M%2C+Behr+J%2C+Buhl+R%2C+Costabel+U%2C+Dekhuijzen+R%2C+Jansen+HM%2C+MacNee+W%2C+Thomeer+M&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa042976&amp;rft_id=info%3Apmid%2F16306520&amp;rft.issue=21&amp;rft.jtitle=N+Engl+J+Med.&amp;rft.pages=2229-2242&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=353" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text">Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. NEnglJMed. 2012 May 24;366:1968–77.</span></li>
<li id="cite_note-NIHApril2013-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-NIHApril2013_41-0">^</a></b></span> <span class="reference-text">Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful <a rel="nofollow" class="external autonumber" href="http://www.nih.gov/news/health/oct2011/nhlbi-21.htm">[1]</a>, Nih.gov., Retrieved 2013-04-11</span></li>
<li id="cite_note-IPFCRN-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-IPFCRN_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">The Idiopathic Pulmonary Fibrosis Clinical Research Network. (2014). "Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis". <i>N Engl J Med.</i> <b>370</b> (22): 2093–2102. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2Fnejmoa1401739">10.1056/nejmoa1401739</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24836309">24836309</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Randomized+trial+of+acetylcysteine+in+idiopathic+pulmonary+fibrosis&amp;rft.aulast=The+Idiopathic+Pulmonary+Fibrosis+Clinical+Research+Network.&amp;rft.au=The+Idiopathic+Pulmonary+Fibrosis+Clinical+Research+Network.&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmoa1401739&amp;rft_id=info%3Apmid%2F24836309&amp;rft.issue=22&amp;rft.jtitle=N+Engl+J+Med.&amp;rft.pages=2093-2102&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=370" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BIBF-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-BIBF_43-0">^</a></b></span> <span class="reference-text">[BIBF 1120 Fact Sheet. Retrieved 2014-04-08: <a rel="nofollow" class="external free" href="http://dl.groovygecko.net/anon.groovy/clients/broadview/shirehealth/04/Vargatef_backgrounder.pdf">http://dl.groovygecko.net/anon.groovy/clients/broadview/shirehealth/04/Vargatef_backgrounder.pdf</a>]</span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm</a></span></li>
<li id="cite_note-CoalitionForPF-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-CoalitionForPF_45-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external autonumber" href="http://www.coalitionforpf.org/active-clinical-trials-and-investigational-research-in-ipf/">[2]</a></span></li>
<li id="cite_note-RussoIribarne-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-RussoIribarne_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Russo MJ, Iribarne A, Hong KN, Davies RR, Xydas S, Takayama H, Ibrahimiye A, Gelijns AC, Bacchetta MD, D'Ovidio F, Arcasoy S, Sonett JR (2010). "High lung allocation score is associated with increased morbidity and mortality following transplantation". <i>Chest</i> <b>137</b> (3): 651–657. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.09-0319">10.1378/chest.09-0319</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=High+lung+allocation+score+is+associated+with+increased+morbidity+and+mortality+following+transplantation&amp;rft.aulast=Russo+MJ%2C+Iribarne+A%2C+Hong+KN%2C+Davies+RR%2C+Xydas+S%2C+Takayama+H%2C+Ibrahimiye+A%2C+Gelijns+AC%2C+Bacchetta+MD%2C+D%27Ovidio+F%2C+Arcasoy+S%2C+Sonett+JR&amp;rft.au=Russo+MJ%2C+Iribarne+A%2C+Hong+KN%2C+Davies+RR%2C+Xydas+S%2C+Takayama+H%2C+Ibrahimiye+A%2C+Gelijns+AC%2C+Bacchetta+MD%2C+D%27Ovidio+F%2C+Arcasoy+S%2C+Sonett+JR&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.09-0319&amp;rft.issue=3&amp;rft.jtitle=Chest&amp;rft.pages=651-657&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=137" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SpagnoloTonelli-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-SpagnoloTonelli_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SpagnoloTonelli_47-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-SpagnoloTonelli_47-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Spagnolo P, Tonelli R, Cocconcelli E, Stefani A, Richeldi L (2012). "Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges". <i>Multidiscip Respir Med.</i> <b>7</b> (1): 42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F2049-6958-7-42">10.1186/2049-6958-7-42</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Idiopathic+pulmonary+fibrosis%3A+diagnostic+pitfalls+and+therapeutic+challenges&amp;rft.aulast=Spagnolo+P%2C+Tonelli+R%2C+Cocconcelli+E%2C+Stefani+A%2C+Richeldi+L&amp;rft.au=Spagnolo+P%2C+Tonelli+R%2C+Cocconcelli+E%2C+Stefani+A%2C+Richeldi+L&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1186%2F2049-6958-7-42&amp;rft.issue=1&amp;rft.jtitle=Multidiscip+Respir+Med.&amp;rft.pages=42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-GeorgeArnaoutakis-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-GeorgeArnaoutakis_48-0">^</a></b></span> <span class="reference-text"><span class="citation journal">George TJ, Arnaoutakis GJ, Shah AS (2007). "Lung transplantation for idiopathic pulmonary fibrosis". <i>Ann Thorac Surg.</i> <b>84</b> (4): 1121–1128. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.athoracsur.2007.04.096">10.1016/j.athoracsur.2007.04.096</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17888957">17888957</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Lung+transplantation+for+idiopathic+pulmonary+fibrosis&amp;rft.au=George+TJ%2C+Arnaoutakis+GJ%2C+Shah+AS&amp;rft.aulast=George+TJ%2C+Arnaoutakis+GJ%2C+Shah+AS&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.athoracsur.2007.04.096&amp;rft_id=info%3Apmid%2F17888957&amp;rft.issue=4&amp;rft.jtitle=Ann+Thorac+Surg.&amp;rft.pages=1121-1128&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=84" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MasonBrizzio-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-MasonBrizzio_49-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mason DP, Brizzio ME, Alster JM, McNeill AM, Murthy SC, Budev MM, Mehta AC, Minai OA et al. (2011). "Lung transplant in idiopathic pulmonary fibrosis". <i>Arch Surg.</i> <b>146</b> (10): 1204–1209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchsurg.2011.239">10.1001/archsurg.2011.239</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Lung+transplant+in+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Mason+DP%2C+Brizzio+ME%2C+Alster+JM%2C+McNeill+AM%2C+Murthy+SC%2C+Budev+MM%2C+Mehta+AC%2C+Minai+OA&amp;rft.au=Mason+DP%2C+Brizzio+ME%2C+Alster+JM%2C+McNeill+AM%2C+Murthy+SC%2C+Budev+MM%2C+Mehta+AC%2C+Minai+OA&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchsurg.2011.239&amp;rft.issue=10&amp;rft.jtitle=Arch+Surg.&amp;rft.pages=1204-1209&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-KeatingLevvey-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-KeatingLevvey_50-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Keating D, Levvey B, Kotsimbos T, Whitford H, Westall G, Williams T, Snell G (2009). "Lung transplantation in pulmonary fibrosis challenging early outcomes counter balanced by surprisingly good outcomes beyond 15 years". <i>Transplant Proc.</i> <b>41</b> (1): 289–291. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.transproceed.2008.10.042">10.1016/j.transproceed.2008.10.042</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19249537">19249537</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Lung+transplantation+in+pulmonary+fibrosis+challenging+early+outcomes+counter+balanced+by+surprisingly+good+outcomes+beyond+15+years&amp;rft.au=Keating+D%2C+Levvey+B%2C+Kotsimbos+T%2C+Whitford+H%2C+Westall+G%2C+Williams+T%2C+Snell+G&amp;rft.aulast=Keating+D%2C+Levvey+B%2C+Kotsimbos+T%2C+Whitford+H%2C+Westall+G%2C+Williams+T%2C+Snell+G&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.transproceed.2008.10.042&amp;rft_id=info%3Apmid%2F19249537&amp;rft.issue=1&amp;rft.jtitle=Transplant+Proc.&amp;rft.pages=289-291&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MorrisonStovall-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-MorrisonStovall_51-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Morrison DA, Stovall JR. (1992). "Increased exercise capacity in hypoxemic patients after long-term oxygen therapy". <i>Chest</i> <b>102</b> (2): 542–550. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.102.2.542">10.1378/chest.102.2.542</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1643945">1643945</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Increased+exercise+capacity+in+hypoxemic+patients+after+long-term+oxygen+therapy&amp;rft.aulast=Morrison+DA%2C+Stovall+JR.&amp;rft.au=Morrison+DA%2C+Stovall+JR.&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.102.2.542&amp;rft_id=info%3Apmid%2F1643945&amp;rft.issue=2&amp;rft.jtitle=Chest&amp;rft.pages=542-550&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=102" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lee-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lee_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee JS, McLaughlin S, Collard HR (2011). "Comprehensive care of the patient with idiopathic pulmonary fibrosis". <i>Current Opinion in Pulmonary Medicine</i> <b>17</b> (5): 348–354. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2Fmcp.0b013e328349721b">10.1097/mcp.0b013e328349721b</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Comprehensive+care+of+the+patient+with+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Lee+JS%2C+McLaughlin+S%2C+Collard+HR&amp;rft.au=Lee+JS%2C+McLaughlin+S%2C+Collard+HR&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2Fmcp.0b013e328349721b&amp;rft.issue=5&amp;rft.jtitle=Current+Opinion+in+Pulmonary+Medicine&amp;rft.pages=348-354&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-KennGloeckl-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-KennGloeckl_53-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kenn, K; Gloeckl, R; Behr, J (2013). "Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis--a review". <i>Respiration; international review of thoracic diseases</i> <b>86</b> (2): 89–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000354112">10.1159/000354112</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23942353">23942353</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Pulmonary+rehabilitation+in+patients+with+idiopathic+pulmonary+fibrosis--a+review&amp;rft.au=Kenn%2C+K%3B+Gloeckl%2C+R%3B+Behr%2C+J&amp;rft.aulast=Kenn%2C+K%3B+Gloeckl%2C+R%3B+Behr%2C+J&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000354112&amp;rft_id=info%3Apmid%2F23942353&amp;rft.issue=2&amp;rft.jtitle=Respiration%3B+international+review+of+thoracic+diseases&amp;rft.pages=89-99&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RyersonBerkeley-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-RyersonBerkeley_54-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR (2011). "Depression and functional status are strongly associated with dyspnea in interstitial lung disease". <i>Chest</i> <b>139</b> (3): 609–616. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Fajrccm-conference.2010.181.1_meetingabstracts.a2960">10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2960</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Depression+and+functional+status+are+strongly+associated+with+dyspnea+in+interstitial+lung+disease&amp;rft.aulast=Ryerson+CJ%2C+Berkeley+J%2C+Carrieri-Kohlman+VL%2C+Pantilat+SZ%2C+Landefeld+CS%2C+Collard+HR&amp;rft.au=Ryerson+CJ%2C+Berkeley+J%2C+Carrieri-Kohlman+VL%2C+Pantilat+SZ%2C+Landefeld+CS%2C+Collard+HR&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Fajrccm-conference.2010.181.1_meetingabstracts.a2960&amp;rft.issue=3&amp;rft.jtitle=Chest&amp;rft.pages=609-616&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=139" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AllenRaut-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-AllenRaut_55-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Allen S, Raut S, Woollard J, Vassallo M (2005). "Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis". <i>Palliat Med.</i> <b>19</b> (2): 128–130. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1191%2F0269216305pm998oa">10.1191/0269216305pm998oa</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Low+dose+diamorphine+reduces+breathlessness+without+causing+a+fall+in+oxygen+saturation+in+elderly+patients+with+end-stage+idiopathic+pulmonary+fibrosis&amp;rft.au=Allen+S%2C+Raut+S%2C+Woollard+J%2C+Vassallo+M&amp;rft.aulast=Allen+S%2C+Raut+S%2C+Woollard+J%2C+Vassallo+M&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1191%2F0269216305pm998oa&amp;rft.issue=2&amp;rft.jtitle=Palliat+Med.&amp;rft.pages=128-130&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AgarwalJindal-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-AgarwalJindal_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AgarwalJindal_56-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Agarwal R, Jindal SK (2008). "Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review". <i>Eur J Intern Med.</i> <b>19</b> (4): 227–235. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ejim.2007.04.024">10.1016/j.ejim.2007.04.024</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Acute+exacerbation+of+idiopathic+pulmonary+fibrosis%3A+a+systematic+review&amp;rft.au=Agarwal+R%2C+Jindal+SK&amp;rft.aulast=Agarwal+R%2C+Jindal+SK&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejim.2007.04.024&amp;rft.issue=4&amp;rft.jtitle=Eur+J+Intern+Med.&amp;rft.pages=227-235&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SternMal-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-SternMal_57-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Stern JB, Mal H, Groussard O, Brugière O, Marceau A, Jebrak G, Fournier M (2001). "Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure". <i>Chest</i> <b>120</b> (1): 213–219. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.120.1.213">10.1378/chest.120.1.213</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Prognosis+of+patients+with+advanced+idiopathic+pulmonary+fibrosis+requiring+mechanical+ventilation+for+acute+respiratory+failure&amp;rft.aulast=Stern+JB%2C+Mal+H%2C+Groussard+O%2C+Brugi%C3%A8re+O%2C+Marceau+A%2C+Jebrak+G%2C+Fournier+M&amp;rft.au=Stern+JB%2C+Mal+H%2C+Groussard+O%2C+Brugi%C3%A8re+O%2C+Marceau+A%2C+Jebrak+G%2C+Fournier+M&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.120.1.213&amp;rft.issue=1&amp;rft.jtitle=Chest&amp;rft.pages=213-219&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BjorakerRyu-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-BjorakerRyu_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BjorakerRyu_58-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BjorakerRyu_58-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP (1998). "Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis". <i>Am J Respir Crit Care Med.</i> <b>157</b> (1): 199–203. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Fajrccm.157.1.9704130">10.1164/ajrccm.157.1.9704130</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9445300">9445300</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Prognostic+significance+of+histopathologic+subsets+in+idiopathic+pulmonary+fibrosis&amp;rft.au=Bjoraker+JA%2C+Ryu+JH%2C+Edwin+MK%2C+Myers+JL%2C+Tazelaar+HD%2C+Schroeder+DR%2C+Offord+KP&amp;rft.aulast=Bjoraker+JA%2C+Ryu+JH%2C+Edwin+MK%2C+Myers+JL%2C+Tazelaar+HD%2C+Schroeder+DR%2C+Offord+KP&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Fajrccm.157.1.9704130&amp;rft_id=info%3Apmid%2F9445300&amp;rft.issue=1&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med.&amp;rft.pages=199-203&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=157" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-KimCollard-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-KimCollard_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-KimCollard_59-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-KimCollard_59-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">King, TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, for the ASCEND Study Group. (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658683">"Classification and natural history of the idiopathic interstitial pneumonias"</a>. <i>Proc Am Thorac Soc.</i> <b>3</b> (4): 285–292. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1513%2Fpats.200601-005TK">10.1513/pats.200601-005TK</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658683">2658683</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16738191">16738191</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Classification+and+natural+history+of+the+idiopathic+interstitial+pneumonias&amp;rft.au=King%2C+TE+Jr.%2C+Bradford+WZ%2C+Castro-Bernardini+S%2C+Fagan+EA%2C+Glaspole+I%2C+Glassberg+MK%2C+Gorina+E%2C+Hopkins+PM%2C+for+the+ASCEND+Study+Group.&amp;rft.aulast=King%2C+TE+Jr.%2C+Bradford+WZ%2C+Castro-Bernardini+S%2C+Fagan+EA%2C+Glaspole+I%2C+Glassberg+MK%2C+Gorina+E%2C+Hopkins+PM%2C+for+the+ASCEND+Study+Group.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2658683&amp;rft_id=info%3Adoi%2F10.1513%2Fpats.200601-005TK&amp;rft_id=info%3Apmc%2F2658683&amp;rft_id=info%3Apmid%2F16738191&amp;rft.issue=4&amp;rft.jtitle=Proc+Am+Thorac+Soc.&amp;rft.pages=285-292&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-LeyRyerson-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-LeyRyerson_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-LeyRyerson_60-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR. "A multidimensional index and staging system for idiopathic pulmonary fibrosis". <i>Annals of Internal Medicine</i> <b>156</b> (10): 684–691. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-156-10-201205150-00004">10.7326/0003-4819-156-10-201205150-00004</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=A+multidimensional+index+and+staging+system+for+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Ley+B%2C+Ryerson+CJ%2C+Vittinghoff+E%2C+Ryu+JH%2C+Tomassetti+S%2C+Lee+JS%2C+Poletti+V%2C+Buccioli+M%2C+Elicker+BM%2C+Jones+KD%2C+King+TE+Jr%2C+Collard+HR&amp;rft.au=Ley+B%2C+Ryerson+CJ%2C+Vittinghoff+E%2C+Ryu+JH%2C+Tomassetti+S%2C+Lee+JS%2C+Poletti+V%2C+Buccioli+M%2C+Elicker+BM%2C+Jones+KD%2C+King+TE+Jr%2C+Collard+HR&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-156-10-201205150-00004&amp;rft.issue=10&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.pages=684-691&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=156" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RyersonVittinghoff-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-RyersonVittinghoff_61-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ et al. (2014). "Predicting Survival Across Chronic Interstitial Lung Disease: The ILD-GAP Model". <i>Chest</i> <b>145</b> (4): 723–728. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.13-1474">10.1378/chest.13-1474</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24114524">24114524</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Predicting+Survival+Across+Chronic+Interstitial+Lung+Disease%3A+The+ILD-GAP+Model&amp;rft.aulast=Ryerson+CJ%2C+Vittinghoff+E%2C+Ley+B%2C+Lee+JS%2C+Mooney+JJ%2C+Jones+KD%2C+Elicker+BM%2C+Wolters+PJ&amp;rft.au=Ryerson+CJ%2C+Vittinghoff+E%2C+Ley+B%2C+Lee+JS%2C+Mooney+JJ%2C+Jones+KD%2C+Elicker+BM%2C+Wolters+PJ&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.13-1474&amp;rft_id=info%3Apmid%2F24114524&amp;rft.issue=4&amp;rft.jtitle=Chest&amp;rft.pages=723-728&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=145" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-KingAlbera-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-KingAlbera_62-0">^</a></b></span> <span class="reference-text"><span class="citation journal">King, TE Jr, Albera C, Bradford WZ, Costabel U, du Bois RM, Leff JA, Nathan SD, Sahn SA et al. (2014). "All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials". <i>Am J Respir Crit Care Med</i> <b>189</b> (7): 825–831. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.201311-1951oc">10.1164/rccm.201311-1951oc</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=All-cause+mortality+rate+in+patients+with+idiopathic+pulmonary+fibrosis.+Implications+for+the+design+and+execution+of+clinical+trials&amp;rft.au=King%2C+TE+Jr%2C+Albera+C%2C+Bradford+WZ%2C+Costabel+U%2C+du+Bois+RM%2C+Leff+JA%2C+Nathan+SD%2C+Sahn+SA&amp;rft.aulast=King%2C+TE+Jr%2C+Albera+C%2C+Bradford+WZ%2C+Costabel+U%2C+du+Bois+RM%2C+Leff+JA%2C+Nathan+SD%2C+Sahn+SA&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.201311-1951oc&amp;rft.issue=7&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med&amp;rft.pages=825-831&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=189" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-PeljtoZhang-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-PeljtoZhang_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO et al. (2013). "Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis". <i>JAMA</i> <b>309</b> (21): 2232–2239. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.2013.5827">10.1001/jama.2013.5827</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23695349">23695349</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Association+between+the+MUC5B+promoter+polymorphism+and+survival+in+patients+with+idiopathic+pulmonary+fibrosis&amp;rft.aulast=Peljto+AL%2C+Zhang+Y%2C+Fingerlin+TE%2C+Ma+SF%2C+Garcia+JG%2C+Richards+TJ%2C+Silveira+LJ%2C+Lindell+KO&amp;rft.au=Peljto+AL%2C+Zhang+Y%2C+Fingerlin+TE%2C+Ma+SF%2C+Garcia+JG%2C+Richards+TJ%2C+Silveira+LJ%2C+Lindell+KO&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2013.5827&amp;rft_id=info%3Apmid%2F23695349&amp;rft.issue=21&amp;rft.jtitle=JAMA&amp;rft.pages=2232-2239&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=309" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-StockSato-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-StockSato_64-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP et al. (2013). "Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis". <i>Thorax</i> <b>68</b> (5): 436–441. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fthoraxjnl-2012-201786">10.1136/thoraxjnl-2012-201786</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23321605">23321605</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Mucin+5B+promoter+polymorphism+is+associated+with+idiopathic+pulmonary+fibrosis+but+not+with+development+of+lung+fibrosis+in+systemic+sclerosis+or+sarcoidosis&amp;rft.aulast=Stock+CJ%2C+Sato+H%2C+Fonseca+C%2C+Banya+WA%2C+Molyneaux+PL%2C+Adamali+H%2C+Russell+AM%2C+Denton+CP&amp;rft.au=Stock+CJ%2C+Sato+H%2C+Fonseca+C%2C+Banya+WA%2C+Molyneaux+PL%2C+Adamali+H%2C+Russell+AM%2C+Denton+CP&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fthoraxjnl-2012-201786&amp;rft_id=info%3Apmid%2F23321605&amp;rft.issue=5&amp;rft.jtitle=Thorax&amp;rft.pages=436-441&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-GribbinHubbard-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-GribbinHubbard_65-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2121155">"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK"</a>. <i>Thorax</i> <b>61</b> (11): 980–985. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fthx.2006.062836">10.1136/thx.2006.062836</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2121155">2121155</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16844727">16844727</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Incidence+and+mortality+of+idiopathic+pulmonary+fibrosis+and+sarcoidosis+in+the+UK&amp;rft.au=Gribbin+J%2C+Hubbard+RB%2C+Le+Jeune+I%2C+Smith+CJ%2C+West+J%2C+Tata+LJ&amp;rft.aulast=Gribbin+J%2C+Hubbard+RB%2C+Le+Jeune+I%2C+Smith+CJ%2C+West+J%2C+Tata+LJ&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2121155&amp;rft_id=info%3Adoi%2F10.1136%2Fthx.2006.062836&amp;rft_id=info%3Apmc%2F2121155&amp;rft_id=info%3Apmid%2F16844727&amp;rft.issue=11&amp;rft.jtitle=Thorax&amp;rft.pages=980-985&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=61" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NavaratnamFleming-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-NavaratnamFleming_66-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB (2011). "The rising incidence of idiopathic pulmonary fibrosis in the U.K.". <i>Thorax</i> <b>66</b> (6): 462–467. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fthx.2010.148031">10.1136/thx.2010.148031</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21525528">21525528</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=The+rising+incidence+of+idiopathic+pulmonary+fibrosis+in+the+U.K.&amp;rft.aulast=Navaratnam+V%2C+Fleming+KM%2C+West+J%2C+Smith+CJ%2C+Jenkins+RG%2C+Fogarty+A%2C+Hubbard+RB&amp;rft.au=Navaratnam+V%2C+Fleming+KM%2C+West+J%2C+Smith+CJ%2C+Jenkins+RG%2C+Fogarty+A%2C+Hubbard+RB&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fthx.2010.148031&amp;rft_id=info%3Apmid%2F21525528&amp;rft.issue=6&amp;rft.jtitle=Thorax&amp;rft.pages=462-467&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-EurostatNewsJuly2010-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-EurostatNewsJuly2010_67-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://epp.eurostat.ec.europa.eu/cache/ITY_PUBLIC/3-27072010-AP/EN/3-27072010-AP-EN.PDF">Eurostat News Release. European demography. 110/2010. 27 July 2010</a></span></li>
<li id="cite_note-HyldgaardHilberg-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-HyldgaardHilberg_68-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hyldgaard C, Hilberg O, Muller A, Bendstrup E (2014). "A cohort study of interstitial lung diseases in central Denmark". <i>Respir Med</i> <b>108</b> (5): 793–799. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.rmed.2013.09.002">10.1016/j.rmed.2013.09.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24636811">24636811</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=A+cohort+study+of+interstitial++lung+diseases+in+central+Denmark&amp;rft.au=Hyldgaard+C%2C+Hilberg+O%2C+Muller+A%2C+Bendstrup+E&amp;rft.aulast=Hyldgaard+C%2C+Hilberg+O%2C+Muller+A%2C+Bendstrup+E&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rmed.2013.09.002&amp;rft_id=info%3Apmid%2F24636811&amp;rft.issue=5&amp;rft.jtitle=Respir+Med&amp;rft.pages=793-799&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=108" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WilliamsMalarkey-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-WilliamsMalarkey_69-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Williams K, Malarkey D, Cohn L, Patrick D, Dye J, Toews G (2004). "Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect". <i>Chest</i> <b>125</b> (6): 2278–2288. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.125.6.2278">10.1378/chest.125.6.2278</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15189952">15189952</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Identification+of+spontaneous+feline+idiopathic+pulmonary+fibrosis%3A+morphology+and+ultrastructural+evidence+for+a+type+II+pneumocyte+defect&amp;rft.aulast=Williams+K%2C+Malarkey+D%2C+Cohn+L%2C+Patrick+D%2C+Dye+J%2C+Toews+G&amp;rft.au=Williams+K%2C+Malarkey+D%2C+Cohn+L%2C+Patrick+D%2C+Dye+J%2C+Toews+G&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.125.6.2278&amp;rft_id=info%3Apmid%2F15189952&amp;rft.issue=6&amp;rft.jtitle=Chest&amp;rft.pages=2278-2288&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=125" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Webb-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-Webb_70-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Webb JA, Armstrong J (2002). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC339552">"Chronic idiopathic pulmonary fibrosis in a West Highland white terrier"</a>. <i>Can Vet J.</i> <b>43</b> (9): 703–705. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC339552">339552</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12240528">12240528</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIdiopathic+pulmonary+fibrosis&amp;rft.atitle=Chronic+idiopathic+pulmonary+fibrosis+in+a+West+Highland+white+terrier&amp;rft.aulast=Webb+JA%2C+Armstrong+J&amp;rft.au=Webb+JA%2C+Armstrong+J&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC339552&amp;rft_id=info%3Apmc%2F339552&amp;rft_id=info%3Apmid%2F12240528&amp;rft.issue=9&amp;rft.jtitle=Can+Vet+J.&amp;rft.pages=703-705&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Canine-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-Canine_71-0">^</a></b></span> <span class="reference-text">Canine Pulmonary Fibrosis.<a rel="nofollow" class="external autonumber" href="http://www.akcchf.org/canine-health/your-dogs-health/canine-pulmonary-fibrosis.html">[3]</a> Akcchf.org. Retrieved 2013-04-11.</span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit&amp;section=20" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="mbox-small plainlinks sistersitebox" style="border:1px solid #aaa;background-color:#f9f9f9">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="//commons.wikimedia.org/wiki/Category:Idiopathic_pulmonary_fibrosis" class="extiw" title="commons:Category:Idiopathic pulmonary fibrosis">Idiopathic pulmonary fibrosis</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="https://www.dmoz.org/Health/Conditions_and_Diseases/Respiratory_Disorders/Pulmonary_Fibrosis/">Idiopathic pulmonary fibrosis</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
<li><a rel="nofollow" class="external text" href="http://www.pulmonaryfibrosis.org/Treatment/">Pulmonary fibrosis foundation</a></li>
<li><a rel="nofollow" class="external text" href="http://www.blf.org.uk/IPF/">IPF - British Lung Foundation</a></li>
<li><a rel="nofollow" class="external text" href="http://www.pulmonary-fibrosis.net/">The European IPF Registry (eurIPFreg) has become Europe's leading database of longitudinal data from IPF patients, including control groups of patients with other lung diseases</a></li>
<li><a rel="nofollow" class="external text" href="http://www.coalitionforpf.org/">Coalition for Pulmonary Fibrosis</a></li>
<li><a rel="nofollow" class="external text" href="http://www.ildcare.nl/index.php?id=19/">ILD CARE FOUNDATION´s activity is focused to increase knowledge, support research, contribute to prevention and provide counselling for interstitial lung diseases</a></li>
<li><a rel="nofollow" class="external text" href="http://www.diagnoseipf.com/">www.diagnoseipf.com</a></li>
<li><a rel="nofollow" class="external text" href="http://knowipfnow.com/">KnowIPFNow.com</a></li>
<li><a rel="nofollow" class="external text" href="http://www.inipf.com/">inIPF</a></li>
<li><a rel="nofollow" class="external text" href="http://ipftoday.com/">IPFtoday.com</a></li>
<li><a rel="nofollow" class="external text" href="http://www.ipfcharter.org">ipfcharter.org</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Respiratory_pathology" title="Template:Respiratory pathology"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Respiratory_pathology" title="Template talk:Respiratory pathology"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Respiratory_pathology&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Pathology" title="Pathology">Pathology</a> of <a href="/wiki/Respiratory_system" title="Respiratory system">respiratory system</a> (<a href="/wiki/ICD-10_Chapter_X:_Diseases_of_the_respiratory_system" title="ICD-10 Chapter X: Diseases of the respiratory system">J</a>, <a href="/wiki/List_of_ICD-9_codes_460%E2%80%93519:_diseases_of_the_respiratory_system" title="List of ICD-9 codes 460–519: diseases of the respiratory system">460–519</a>), <a href="/wiki/Respiratory_disease" title="Respiratory disease">respiratory diseases</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Upper_respiratory_tract_infection" title="Upper respiratory tract infection">Upper RT</a><br />
(including <a href="/wiki/Upper_respiratory_tract_infection" title="Upper respiratory tract infection">URTIs</a>,<br />
<a href="/wiki/Common_cold" title="Common cold">Common cold</a>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Human_head" title="Human head">Head</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dt><i><a href="/wiki/Paranasal_sinuses" title="Paranasal sinuses">sinuses</a></i></dt>
<dd><a href="/wiki/Sinusitis" title="Sinusitis">Sinusitis</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Nose_disease" title="Nose disease" class="mw-redirect">nose</a></i></dt>
<dd><a href="/wiki/Rhinitis" title="Rhinitis">Rhinitis</a>
<dl>
<dd><a href="/wiki/Vasomotor_rhinitis" title="Vasomotor rhinitis" class="mw-redirect">Vasomotor rhinitis</a></dd>
<dd><a href="/wiki/Atrophic_rhinitis" title="Atrophic rhinitis" class="mw-redirect">Atrophic rhinitis</a></dd>
<dd><a href="/wiki/Hay_fever" title="Hay fever" class="mw-redirect">Hay fever</a></dd>
</dl>
</dd>
<dd><a href="/wiki/Nasal_polyp" title="Nasal polyp">Nasal polyp</a></dd>
<dd><a href="/wiki/Rhinorrhea" title="Rhinorrhea">Rhinorrhea</a></dd>
<dd><i><a href="/wiki/Nasal_septum" title="Nasal septum">nasal septum</a></i>
<dl>
<dd><a href="/wiki/Nasal_septum_deviation" title="Nasal septum deviation">Nasal septum deviation</a></dd>
<dd><a href="/wiki/Nasal_septum_perforation" title="Nasal septum perforation">Nasal septum perforation</a></dd>
<dd><a href="/wiki/Nasal_septal_hematoma" title="Nasal septal hematoma">Nasal septal hematoma</a></dd>
</dl>
</dd>
</dl>
<dl>
<dt><i><a href="/wiki/Tonsil" title="Tonsil">tonsil</a></i></dt>
<dd><a href="/wiki/Tonsillitis" title="Tonsillitis">Tonsillitis</a></dd>
<dd><a href="/wiki/Adenoid_hypertrophy" title="Adenoid hypertrophy">Adenoid hypertrophy</a></dd>
<dd><a href="/wiki/Peritonsillar_abscess" title="Peritonsillar abscess">Peritonsillar abscess</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Neck" title="Neck">Neck</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dt><i><a href="/wiki/Human_pharynx" title="Human pharynx" class="mw-redirect">pharynx</a></i></dt>
<dd><a href="/wiki/Pharyngitis" title="Pharyngitis">Pharyngitis</a>
<dl>
<dd><a href="/wiki/Streptococcal_pharyngitis" title="Streptococcal pharyngitis">Strep throat</a></dd>
</dl>
</dd>
<dd><a href="/wiki/Laryngopharyngeal_reflux" title="Laryngopharyngeal reflux">Laryngopharyngeal reflux</a> (LPR)</dd>
<dd><a href="/wiki/Retropharyngeal_abscess" title="Retropharyngeal abscess">Retropharyngeal abscess</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Larynx" title="Larynx">larynx</a></i></dt>
<dd><a href="/wiki/Croup" title="Croup">Croup</a></dd>
<dd><a href="/wiki/Laryngomalacia" title="Laryngomalacia">Laryngomalacia</a></dd>
<dd><a href="/wiki/Laryngeal_cyst" title="Laryngeal cyst">Laryngeal cyst</a></dd>
<dd><a href="/wiki/Laryngitis" title="Laryngitis">Laryngitis</a></dd>
<dd><a href="/wiki/Laryngopharyngeal_reflux" title="Laryngopharyngeal reflux">Laryngopharyngeal reflux</a> (LPR)</dd>
<dd><a href="/wiki/Laryngospasm" title="Laryngospasm">Laryngospasm</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Vocal_folds" title="Vocal folds">vocal folds</a></i></dt>
<dd><a href="/wiki/Laryngopharyngeal_reflux" title="Laryngopharyngeal reflux">Laryngopharyngeal reflux</a> (LPR)</dd>
<dd><a href="/wiki/Vocal_fold_nodule" title="Vocal fold nodule">Vocal fold nodule</a></dd>
<dd><a href="/wiki/Vocal_cord_paresis" title="Vocal cord paresis">Vocal cord paresis</a></dd>
<dd><a href="/wiki/Vocal_cord_dysfunction" title="Vocal cord dysfunction">Vocal cord dysfunction</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Epiglottis" title="Epiglottis">epiglottis</a></i></dt>
<dd><a href="/wiki/Epiglottitis" title="Epiglottitis">Epiglottitis</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Tracheal_disease" title="Tracheal disease" class="mw-redirect">trachea</a></i></dt>
<dd><a href="/wiki/Tracheitis" title="Tracheitis">Tracheitis</a></dd>
<dd><a href="/wiki/Tracheal_stenosis" title="Tracheal stenosis" class="mw-redirect">Tracheal stenosis</a></dd>
</dl>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lower_respiratory_tract" title="Lower respiratory tract" class="mw-redirect">Lower RT</a>/<a href="/wiki/Lung_disease" title="Lung disease" class="mw-redirect">lung disease</a><br />
(including <a href="/wiki/Lower_respiratory_tract_infection" title="Lower respiratory tract infection">LRTIs</a>)</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Bronchus" title="Bronchus">Bronchial</a>/<br />
<a href="/wiki/Obstructive_lung_disease" title="Obstructive lung disease">obstructive</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dt><i>acute</i></dt>
<dd><a href="/wiki/Acute_bronchitis" title="Acute bronchitis">Acute bronchitis</a></dd>
</dl>
<dl>
<dt><i>chronic</i></dt>
<dd><a href="/wiki/Chronic_obstructive_pulmonary_disease" title="Chronic obstructive pulmonary disease">COPD</a>
<dl>
<dd><a href="/wiki/Chronic_bronchitis" title="Chronic bronchitis" class="mw-redirect">Chronic bronchitis</a></dd>
<dd><a href="/wiki/Acute_exacerbations_of_chronic_bronchitis" title="Acute exacerbations of chronic bronchitis" class="mw-redirect">Acute exacerbations of chronic bronchitis</a></dd>
<dd><a href="/wiki/Acute_exacerbation_of_chronic_obstructive_pulmonary_disease" title="Acute exacerbation of chronic obstructive pulmonary disease">Acute exacerbation of COPD</a></dd>
<dd><a href="/wiki/Emphysema" title="Emphysema" class="mw-redirect">Emphysema</a>)</dd>
<dd><a href="/wiki/Asthma" title="Asthma">Asthma</a> (<a href="/wiki/Status_asthmaticus" title="Status asthmaticus" class="mw-redirect">Status asthmaticus</a></dd>
<dd><a href="/wiki/Aspirin-induced_asthma" title="Aspirin-induced asthma">Aspirin-induced</a></dd>
<dd><a href="/wiki/Exercise-induced_asthma" title="Exercise-induced asthma" class="mw-redirect">Exercise-induced</a></dd>
</dl>
</dd>
<dd><a href="/wiki/Bronchiectasis" title="Bronchiectasis">Bronchiectasis</a></dd>
</dl>
<dl>
<dt><i>unspecified</i></dt>
<dd><a href="/wiki/Bronchitis" title="Bronchitis">Bronchitis</a></dd>
<dd><a href="/wiki/Bronchiolitis" title="Bronchiolitis">Bronchiolitis</a>
<dl>
<dd><a href="/wiki/Bronchiolitis_obliterans" title="Bronchiolitis obliterans">Bronchiolitis obliterans</a></dd>
</dl>
</dd>
<dd><a href="/wiki/Diffuse_panbronchiolitis" title="Diffuse panbronchiolitis">Diffuse panbronchiolitis</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Interstitial_lung_disease" title="Interstitial lung disease">Interstitial</a>/<br />
<a href="/wiki/Restrictive_lung_disease" title="Restrictive lung disease">restrictive</a><br />
(<a href="/wiki/Pulmonary_fibrosis" title="Pulmonary fibrosis">fibrosis</a>)</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">External agents/<br />
<a href="/wiki/Occupational_disease" title="Occupational disease">occupational</a><br />
<a href="/wiki/Occupational_lung_disease" title="Occupational lung disease">lung disease</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dd><a href="/wiki/Pneumoconiosis" title="Pneumoconiosis">Pneumoconiosis</a>
<dl>
<dd><a href="/wiki/Asbestosis" title="Asbestosis">Asbestosis</a></dd>
<dd><a href="/wiki/Baritosis" title="Baritosis">Baritosis</a></dd>
<dd><a href="/wiki/Bauxite_fibrosis" title="Bauxite fibrosis">Bauxite fibrosis</a></dd>
<dd><a href="/wiki/Berylliosis" title="Berylliosis">Berylliosis</a></dd>
<dd><a href="/wiki/Caplan%27s_syndrome" title="Caplan's syndrome">Caplan's syndrome</a></dd>
<dd><a href="/wiki/Chalicosis" title="Chalicosis">Chalicosis</a></dd>
<dd><a href="/wiki/Coalworker%27s_pneumoconiosis" title="Coalworker's pneumoconiosis">Coalworker's pneumoconiosis</a></dd>
<dd><a href="/wiki/Siderosis" title="Siderosis">Siderosis</a></dd>
<dd><a href="/wiki/Silicosis" title="Silicosis">Silicosis</a></dd>
<dd><a href="/wiki/Pulmonary_talcosis" title="Pulmonary talcosis">Talcosis</a></dd>
<dd><a href="/wiki/Byssinosis" title="Byssinosis">Byssinosis</a></dd>
</dl>
</dd>
</dl>
<dl>
<dd><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a>
<dl>
<dd><a href="/wiki/Bagassosis" title="Bagassosis">Bagassosis</a></dd>
<dd><a href="/wiki/Bird_fancier%27s_lung" title="Bird fancier's lung">Bird fancier's lung</a></dd>
<dd><a href="/wiki/Farmer%27s_lung" title="Farmer's lung">Farmer's lung</a></dd>
<dd><a href="/wiki/Lycoperdonosis" title="Lycoperdonosis">Lycoperdonosis</a></dd>
</dl>
</dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_respiratory_distress_syndrome" title="Acute respiratory distress syndrome">ARDS</a></li>
<li><a href="/wiki/Pulmonary_edema" title="Pulmonary edema">Pulmonary edema</a></li>
<li><a href="/wiki/L%C3%B6ffler%27s_syndrome" title="Löffler's syndrome">Löffler's syndrome</a>/<a href="/wiki/Eosinophilic_pneumonia" title="Eosinophilic pneumonia">Eosinophilic pneumonia</a></li>
<li><a href="/wiki/Respiratory_hypersensitivity" title="Respiratory hypersensitivity" class="mw-redirect">Respiratory hypersensitivity</a>
<ul>
<li><a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a></li>
</ul>
</li>
<li><a href="/wiki/Hamman-Rich_syndrome" title="Hamman-Rich syndrome" class="mw-redirect">Hamman-Rich syndrome</a></li>
<li><strong class="selflink">Idiopathic pulmonary fibrosis</strong></li>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Obstructive or<br />
restrictive</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pneumonia" title="Pneumonia">Pneumonia</a>/<br />
<a href="/wiki/Pneumonitis" title="Pneumonitis">pneumonitis</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">By pathogen</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Viral_pneumonia" title="Viral pneumonia">Viral</a></li>
<li><a href="/wiki/Bacterial_pneumonia" title="Bacterial pneumonia">Bacterial</a>
<ul>
<li><a href="/wiki/Pneumococcal_infection" title="Pneumococcal infection">Pneumococcal</a></li>
<li><a href="/wiki/Klebsiella_pneumonia" title="Klebsiella pneumonia">Klebsiella</a>)</li>
</ul>
</li>
<li><a href="/wiki/Atypical_pneumonia" title="Atypical pneumonia">Atypical bacterial</a>
<ul>
<li><a href="/wiki/Mycoplasma_pneumonia" title="Mycoplasma pneumonia">Mycoplasma</a></li>
<li><a href="/wiki/Legionellosis" title="Legionellosis" class="mw-redirect">Legionnaires' disease</a></li>
<li><a href="/wiki/Chlamydiae" title="Chlamydiae">Chlamydiae</a></li>
</ul>
</li>
<li><a href="/wiki/Fungal_pneumonia" title="Fungal pneumonia">Fungal</a>
<ul>
<li><a href="/wiki/Pneumocystis_pneumonia" title="Pneumocystis pneumonia">Pneumocystis</a></li>
</ul>
</li>
<li><a href="/wiki/Parasitic_pneumonia" title="Parasitic pneumonia">Parasitic</a></li>
<li><i>noninfectious</i>
<ul>
<li><a href="/wiki/Chemical_pneumonia" title="Chemical pneumonia" class="mw-redirect">Chemical</a>/<a href="/wiki/Mendelson%27s_syndrome" title="Mendelson's syndrome">Mendelson's syndrome</a></li>
<li><a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">Aspiration</a>/<a href="/wiki/Lipid_pneumonia" title="Lipid pneumonia">Lipid</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">By vector/route</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Community-acquired_pneumonia" title="Community-acquired pneumonia">Community-acquired</a></li>
<li><a href="/wiki/Healthcare-associated_pneumonia" title="Healthcare-associated pneumonia" class="mw-redirect">Healthcare-associated</a></li>
<li><a href="/wiki/Hospital-acquired_pneumonia" title="Hospital-acquired pneumonia">Hospital-acquired</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">By distribution</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Bronchopneumonia" title="Bronchopneumonia">Broncho-</a></li>
<li><a href="/wiki/Lobar_pneumonia" title="Lobar pneumonia">Lobar</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Idiopathic_interstitial_pneumonia" title="Idiopathic interstitial pneumonia">IIP</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Usual_interstitial_pneumonia" title="Usual interstitial pneumonia">UIP</a></li>
<li><a href="/wiki/Desquamative_interstitial_pneumonia" title="Desquamative interstitial pneumonia">DIP</a></li>
<li><a href="/wiki/Bronchiolitis_obliterans_organizing_pneumonia" title="Bronchiolitis obliterans organizing pneumonia">BOOP-COP</a></li>
<li><a href="/wiki/Nonspecific_interstitial_pneumonia" title="Nonspecific interstitial pneumonia" class="mw-redirect">NSIP</a></li>
<li><a href="/wiki/Respiratory_bronchiolitis" title="Respiratory bronchiolitis" class="mw-redirect">RB</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Atelectasis" title="Atelectasis">Atelectasis</a></li>
<li><i>circulatory</i>
<ul>
<li><a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">Pulmonary hypertension</a></li>
<li><a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">Pulmonary embolism</a></li>
</ul>
</li>
<li><a href="/wiki/Lung_abscess" title="Lung abscess">Lung abscess</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pleural_cavity" title="Pleural cavity">Pleural cavity</a>/<br />
<a href="/wiki/Mediastinum" title="Mediastinum">mediastinum</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pleural_disease" title="Pleural disease">Pleural disease</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pleurisy" title="Pleurisy">Pleuritis/pleurisy</a></li>
</ul>
<ul>
<li><a href="/wiki/Pneumothorax" title="Pneumothorax">Pneumothorax</a>/<a href="/wiki/Hemopneumothorax" title="Hemopneumothorax">Hemopneumothorax</a></li>
</ul>
<dl>
<dt><a href="/wiki/Pleural_effusion" title="Pleural effusion">Pleural effusion</a></dt>
<dd><a href="/wiki/Hemothorax" title="Hemothorax">Hemothorax</a></dd>
<dd><a href="/wiki/Hydrothorax" title="Hydrothorax">Hydrothorax</a></dd>
<dd><a href="/wiki/Chylothorax" title="Chylothorax">Chylothorax</a></dd>
<dd><a href="/wiki/Pleural_empyema" title="Pleural empyema">Empyema/pyothorax</a></dd>
<dd><a href="/wiki/Malignant_pleural_effusion" title="Malignant pleural effusion">Malignant</a></dd>
</dl>
<dl>
<dd><a href="/wiki/Fibrothorax" title="Fibrothorax">Fibrothorax</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mediastinal_disease" title="Mediastinal disease" class="mw-redirect">Mediastinal disease</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Mediastinitis" title="Mediastinitis">Mediastinitis</a></li>
<li><a href="/wiki/Pneumomediastinum" title="Pneumomediastinum">Mediastinal emphysema</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other/general</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Respiratory_failure" title="Respiratory failure">Respiratory failure</a></li>
<li><a href="/wiki/Influenza" title="Influenza">Influenza</a></li>
<li><a href="/wiki/Severe_acute_respiratory_syndrome" title="Severe acute respiratory syndrome">SARS</a></li>
<li><a href="/wiki/Idiopathic_pulmonary_haemosiderosis" title="Idiopathic pulmonary haemosiderosis">Idiopathic pulmonary haemosiderosis</a></li>
<li><a href="/wiki/Pulmonary_alveolar_proteinosis" title="Pulmonary alveolar proteinosis">Pulmonary alveolar proteinosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Respiratory_system_navs" title="Template:Respiratory system navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Respiratory_system_navs" title="Template talk:Respiratory system navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Respiratory_system_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Respiratory_system" title="Respiratory system">respiratory system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Anatomy
<ul>
<li><a href="/wiki/Template:Nose_anatomy" title="Template:Nose anatomy">nose</a></li>
<li><a href="/wiki/Template:Larynx_anatomy" title="Template:Larynx anatomy">larynx</a></li>
<li><a href="/wiki/Template:Lower_respiratory_system_anatomy" title="Template:Lower respiratory system anatomy">lower</a></li>
<li><a href="/wiki/Template:Thoracic_cavity" title="Template:Thoracic cavity">thorax</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Respiratory_physiology" title="Template:Respiratory physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_respiratory_system" title="Template:Development of respiratory system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_respiratory_system" title="Template:Congenital malformations and deformations of respiratory system">Congenital</a></li>
<li><a href="/wiki/Template:Respiratory_neoplasia" title="Template:Respiratory neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Chest_trauma" title="Template:Chest trauma">Chest trauma</a></li>
<li>Infection
<ul>
<li><a href="/wiki/Template:Common_cold" title="Template:Common cold">common cold</a></li>
<li><a href="/wiki/Template:Pneumonia" title="Template:Pneumonia">pneumonia</a></li>
<li><a href="/wiki/Template:Tuberculosis" title="Template:Tuberculosis">tuberculosis</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Respiratory_pathology" title="Template:Respiratory pathology">Other</a></li>
<li><a href="/wiki/Template:Respiratory_system_symptoms_and_signs" title="Template:Respiratory system symptoms and signs">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Respiratory_system_procedures" title="Template:Respiratory system procedures">Procedures</a>
<ul>
<li><a href="/wiki/Template:Mechanical_ventilation" title="Template:Mechanical ventilation">mechanical ventilation</a></li>
</ul>
</li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Nasal_preparations" title="Template:Nasal preparations">nasal</a></li>
<li><a href="/wiki/Template:Throat_preparations" title="Template:Throat preparations">throat</a></li>
<li><a href="/wiki/Template:Drugs_for_obstructive_airway_diseases" title="Template:Drugs for obstructive airway diseases">obstructive airway diseases</a></li>
<li><a href="/wiki/Template:Cough_and_cold_preparations" title="Template:Cough and cold preparations">cough and cold</a></li>
<li><a href="/wiki/Template:Histaminergics" title="Template:Histaminergics">histaminergics</a></li>
<li><a href="/wiki/Template:PAH_rx" title="Template:PAH rx" class="mw-redirect">pulmonary arterial hypertension</a></li>
<li><a href="/wiki/Template:Other_respiratory_system_products" title="Template:Other respiratory system products">other</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Thoracic_surgery" title="Template:Thoracic surgery">Surgery</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1217
CPU time usage: 0.863 seconds
Real time usage: 0.988 seconds
Preprocessor visited node count: 7651/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 253577/2097152 bytes
Template argument size: 15009/2097152 bytes
Highest expansion depth: 16/40
Expensive parser function count: 1/500
Lua time usage: 0.245/10.000 seconds
Lua memory usage: 3.16 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  762.182      1 - -total
 51.99%  396.257      1 - Template:Reflist
 24.10%  183.653     57 - Template:Cite_journal
 20.76%  158.221      8 - Template:Navbox
 15.74%  119.957      1 - Template:Infobox_disease
 14.21%  108.272      1 - Template:Infobox
 11.14%   84.932      1 - Template:Respiratory_pathology
 10.14%   77.308      6 - Template:Navbox_subgroup
  4.05%   30.854      1 - Template:Cite_web
  2.58%   19.684      1 - Template:Respiratory_system_navs
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:8768565-0!*!0!!en!4!* and timestamp 20150711035333 and revision id 650179698
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;oldid=650179698">https://en.wikipedia.org/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;oldid=650179698</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Respiratory_diseases_principally_affecting_the_interstitium" title="Category:Respiratory diseases principally affecting the interstitium">Respiratory diseases principally affecting the interstitium</a></li><li><a href="/wiki/Category:Idiopathic_diseases" title="Category:Idiopathic diseases">Idiopathic diseases</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_with_hAudio_microformats" title="Category:Articles with hAudio microformats">Articles with hAudio microformats</a></li><li><a href="/wiki/Category:Commons_category_with_local_link_same_as_on_Wikidata" title="Category:Commons category with local link same as on Wikidata">Commons category with local link same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Idiopathic+pulmonary+fibrosis&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Idiopathic+pulmonary+fibrosis" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Idiopathic_pulmonary_fibrosis"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Idiopathic_pulmonary_fibrosis"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Idiopathic_pulmonary_fibrosis" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Idiopathic_pulmonary_fibrosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Idiopathic_pulmonary_fibrosis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;oldid=650179698" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q2290446" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Idiopathic_pulmonary_fibrosis&amp;id=650179698" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Idiopathic+pulmonary+fibrosis">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Idiopathic+pulmonary+fibrosis&amp;oldid=650179698&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%AA%D9%84%D9%8A%D9%81_%D8%B1%D8%A6%D9%88%D9%8A_%D9%85%D8%AC%D9%87%D9%88%D9%84_%D8%A7%D9%84%D8%B3%D8%A8%D8%A8" title="تليف رئوي مجهول السبب – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Fibrosi_pulmonar_idiop%C3%A0tica" title="Fibrosi pulmonar idiopàtica – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Idiopathische_interstitielle_Pneumonie#Idiopathische_pulmonale_Fibrose_.28IPF.29" title="Idiopathische interstitielle Pneumonie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%99%CE%B4%CE%B9%CE%BF%CF%80%CE%B1%CE%B8%CE%AE%CF%82_%CE%A0%CE%BD%CE%B5%CF%85%CE%BC%CE%BF%CE%BD%CE%B9%CE%BA%CE%AE_%CE%8A%CE%BD%CF%89%CF%83%CE%B7" title="Ιδιοπαθής Πνευμονική Ίνωση – Greek" lang="el" hreflang="el">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Fibrosis_pulmonar_idiop%C3%A1tica" title="Fibrosis pulmonar idiopática – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Fibrose_pulmonaire_idiopathique" title="Fibrose pulmonaire idiopathique – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Fibrosi_polmonare_idiopatica" title="Fibrosi polmonare idiopatica – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E7%89%B9%E7%99%BA%E6%80%A7%E8%82%BA%E7%B7%9A%E7%B6%AD%E7%97%87" title="特発性肺線維症 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Idiopatyczne_w%C5%82%C3%B3knienie_p%C5%82uc" title="Idiopatyczne włóknienie płuc – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Idiopaattinen_keuhkofibroosi" title="Idiopaattinen keuhkofibroosi – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Idiopatisk_lungfibros" title="Idiopatisk lungfibros – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E7%89%B9%E5%8F%91%E6%80%A7%E8%82%BA%E7%BA%A4%E7%BB%B4%E5%8C%96" title="特发性肺纤维化 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q2290446#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 6 March 2015, at 18:41.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Idiopathic_pulmonary_fibrosis&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","mw.PopUpMediaTransform":"loading","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=mw.PopUpMediaTransform\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":104,"wgHostname":"mw1183"});
}</script>
	</body>
</html>
